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ABSTRACT OF THE DISSERTATION
Modeling Treatment Outcomes in Eating Disorders:
Does Therapist Feedback Support Individually Tailored Service Allocation?
by
Kathryn Grace Truitt
Doctor of Philosophy, Graduate Program in Clinical Psychology
Loma Linda University, March 2011
David A. Vermeersch, Chairperson
Eating disorders are notoriously difficult and costly to treat, with only 40% of
individuals with an eating disorder making a full recovery. Individually Tailored Service
Allocation provides a dynamic treatment model defined by empirically accepted theory
and consistently informed by data provided by the patient. The use of patient feedback
allows for the tailoring of individual treatment plans to meet the unique and varied needs
of each patient. Hierarchical Linear Modeling was used to examine the effect of
Individually Tailored Service Allocation on eating disorder treatment outcomes. A total
of 51 adult women meeting diagnostic criteria for an eating disorder participated in this
study. Participants were randomly assigned to treatment as usual or individually tailored
treatment groups. Changes in psychological dysfunction and distress were measured biweekly throughout the course of treatment using the Outcome Questionnaire 45. The
results of this study indicate variability in levels of global psychological dysfunction
(both within and between subjects) throughout the course of treatment appear to be the
norm, rather than an exception, and this variability is related to eating disorder treatment
outcomes. The choice of treatment methodology and level of Individually Tailored
Service Allocation has the ability to drastically shift treatment outcomes.

xiv

Introduction

“Eating disorders are one the most troubling behavioral disorders in our
society. Eating disorders rob girls and young women of their future and, not
uncommonly, their lives.” (Park, 2007)

The psychological, physical, and social costs of an eating disorder are extremely
high (Levine & Smolak, 2005). Anorexia nervosa has a projected mortality rate of 5%
(Birmingham, Su, Hlynsky, Goldner, & Gao, 2005), and lifetime prevalence for bulimia
nervosa is estimated to be 5% for females (Lewinsohn, Striegel-Moore, & Seeley, 2000).
Individuals suffering from an eating disorder have a suicide risk that is 50 times higher
than that of the general population (Park, 2007). Treatment is often costly and slow, with
estimates for length of recovery ranging from 57 to 79 months (APA Work Group on
Eating Disorders, 2000). Only 40% of individuals diagnosed with an eating disorder,
even with treatment, will recover, with 20% obtaining partial recovery, experiencing no
recovery, or dying. Even more disconcerting, only 1 in 10 males or females suffering
from an eating disorder will get treatment for it. Only 35% of those 1 in 10 individuals
will receive treatment at a facility that specializes in treating eating disorders
(Noordenbox, 2002).
Three primary eating disorders are recognized diagnostically: anorexia nervosa,
bulimia nervosa, and eating disorder not otherwise specified (NOS). Of these three
diagnoses, there are 10 subtypes of eating disorders, none of which are a completely
separate diagnostic and treatable entity from the others (Wonderlich, Joiner, Keel,
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Williamson, & Crosby, 2007). To further complicate the presentation of an individual
with an eating disorder, such individuals typically present with both Axis I and Axis II
psychiatric disorders, including anxiety, depression, body dysmorphic disorder, obsessive
compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and substance abuse
disorders (Costin, 1999; Kaye, Bulik, Thorton, Barbarich, & Masters, 2004). Eating
disorders are also typically accompanied by neurological and cardiovascular difficulties
(Chavez & Insel, 2007). Despite hundreds of research investigations examining etiology,
comorbidities, correlating factors, neurological presentations, treatment, and outcome
results, there are still more questions than answers about eating disorders.
Eating disorders are particularly troubling due to their chronic state and nebulous
psychological presentation. There are no commonly accepted and empirically
proven psychotherapeutic interventions for the treatment of either anorexia or bulimia.
There is a dearth of objective research studies examining the effectiveness of anorexia
treatments. In the few studies that do try to examine anorexia treatments effectively, no
single treatment paradigm has demonstrated a clear advantage over the others (Chavez &
Insel, 2007). Research on anorexia faces many large hurdles impeding the development
and implementation of evidence-based treatments.
The study of the treatment of bulimia has, fortunately, better results. Fluoxetine, a
serotonin reuptake inhibitor, has shown promising results in reducing binge/purge
behaviors, improving food and eating-related attitudes, as well as reducing the rate of
short-term relapse (Beaumont, Russell, Touyz, Buckley, Lowinger, et al., 1997;
Goldstein, Wilson, Thompson, Potvin, & Rampey, 1995; Romano, Halmi, Sarkar, Koke,
& Lee, 2002). Fluoxetine is currently the only Food and Drug Administration-approved
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treatment for any eating disorder. A variety of psychotherapeutic interventions have been
examined for effectiveness in the treatment of bulimia, including cognitive behavioral
therapy (CBT), interpersonal therapy (IPT), and dialectical behavioral therapy (DBT),
amongst others. CBT is currently considered the most effective form of treatment for
bulimia, preferably alongside the use of an antidepressant (Walsh, Fairburn, Mickley,
Sysko, & Parides, 2004). Unfortunately, much like in the treatment of anorexia, there are
still many more treatment nonresponders than responders, indicating a continued need for
further research into treatments, comorbid factors and diagnoses, and their etiology.
Additionally, although numerous eating disorder interventions have been evaluated, the
majority have only achieved modest success. A recent meta-analysis conducted by Stice
et al. (2007) reported that out of 51 eating disorder treatment programs, only 9 served to
reduce risk factors and/or the symptoms of eating disorders and have these changes still
be present at follow-up.
Almost all treatment methodologies for eating disorders are taken from treatment
protocols for other disorders. In large part this is because so little is understood about the
underlying neurological and pathophysiological presentations of eating disorders.
Understanding an eating disorder is difficult, if not impossible, without a
comprehensive picture of the role of interpersonal, intrapersonal, sociological, cultural,
and physiological factors in the disorder. While large amounts of research investigating
food- and body-related factors have been conducted, it was not until very recently that the
pathophysiology of eating disorders was considered (Chavez & Insel, 2007).
Recent investigations into the neurological underpinnings of mental disorders
have illuminated abnormal activity in the central nervous system, encouraging some
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scientists to claim that a mental illness may, in fact, be a brain disorder. Investigators
have begun to supplement the observational and behavioral tools of psychology with the
tools more commonly reserved for medical illness, i.e., positron emission tomography
(PET) scans, functional magnetic resonance imaging (fMRI), and single photon emission
computed tomography (SPECT), amongst others. It is hoped that insights provided by
these modern tools of neuroscience will provide more information on how to effectively
treat eating disorders.
Modern advances in our understanding of these illnesses give us the opportunity
to re-evaluate the etiology of this disease. For instance, weight loss and binge/purge
cycles are now felt to be the outward manifestation of more significant underlying
psychological illness. Although these are the features still used to identify and diagnose
the disorders based on Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition, Text Revision (DSM-IV-TR) categories, there is the possibility that the grouping
of symptoms into classification lists by behavior is overly simplified. Numerous studies
have elucidated many other factors in eating disorders, including not only biological
factors such as genetic predisposition and neurological dysfunction, but also personality
characteristics, abuse histories, traumatic incidents, and developmental challenges
(Anderluh et al., 2003; Berretinni, 2004; Fairburn & Harrison, 2003; Keel & Klump,
2003). These different etiological factors are readily apparent in the manifestation of
eating disorder symptomology.
While each patient presents with similar symptoms causing him or her to be
recognized as having an eating disorder, there can be different underlying causes of the
eating disorder. For instance, patients may present with childhood abuse/PTSD, OCD
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features, depression, or anxiety as the key contributing factor. As these patients receive
treatment, therapy is often tailored to assist the patient in resolving these particular issues
as well as address more generalized symptoms such as body image and nutrition. Due to
the large variety of underlying factors resulting in an eating disorder, it may be necessary
to explore response to treatment by gauging underlying etiologic patterns rather than
seeking a single therapeutic technique to treat all patients. Tailoring therapy to the unique
etiology of each patient may prove to be the most efficacious form of treatment for eating
disorders. Ultimately, as stated by de la Rie, Noordenbos, Donker, and Furth (2006),
“Evidence based clinical practice regarding treatment for any eating disorder should be
founded on research on the efficacy, effectiveness, and efficiency of different treatment
options as well as the clinical and physical circumstances and the patient’s preferences.”
The current diagnostic categories for eating disorders do not take into
consideration the variety of symptom presentations and possible etiologic patterns of
each individual. There are two primary diagnostic systems used throughout the world, the
Diagnostic and Statistical Manual of Mental Disorders (4th ed; DSM-IV; American
Psychiatric Association, 1994) and the International Statistical Classification of Diseases
and Related Health Problems (10th revision; ICD-10; World Health Organization, 1992).
Despite the careful consideration and review that both manuals undergo before
publication, there is rising speculation that the real-world applicability and validity of the
DSM-IV categories are limited (Wonderlich, Joiner, Keel, Williamson, & Crosby, 2007).
In particular, the diagnostic categories of eating disorders are best interpreted as
diagnostic constructs that are open to change and are easily falsifiable (Skinner, 1986),
instead of distinct disease entities.

5

Proposed Etiology of Eating Disorders
The etiology of eating disorders is virtually unknown. Numerous possibilities
have been suggested, such as genetic predisposition, cultural influences, neurotransmitter
imbalances, temperament, and familial influences (Smolak & Levine, 2006). Explanatory
theories for the etiology of eating disorders are widespread and just as varied. As Stiegler
(2007) claimed, “Arguably, eating disorders have inspired more shifts in explanatory
paradigms over a shorter span of time than have any other class of syndromes in the
history of psychiatry.” Anorexia was initially considered to be the result of the
“refrigerator mom” who drove her children into food refusal as their only means of selfassertion. Bulimia was initially seen as a “protest” against parental hostility or even
cruelty that would lead afflicted girls to pursue unmet needs through rampant binging
followed by a rejection of what they were given with compensatory purging (Stiegler,
2007). Throughout the 1980s and 1990s, the paradigm moved to one of conceptualizing
eating disorders as culture-bound syndromes, driven by western society’s over-emphasis
on how one looks, how one behaves, and the overwhelming media presence. Again, new
research arose that found these theories lacking. Incidents of eating disorders began to
appear in cultures never touched by western societies, and historical investigations found
eating disorders in cultures not subject to modern mores or media. New theories seek to
link anorexia and bulimia to abnormalities in the brain and genetic causes.
There may be no single explanation for eating disorders. As with their
multifaceted presentation, complete with numerous possible comorbidities, manifesting
in a variety of cultures, ages, and developmental histories, their theoretical presentation
may be equally complex. Eating disorders may be the result of interplay between nature
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and nurture. The complexities in etiology only serve to further complicate the healthcare
community’s attempts to find successful prevention and treatment strategies. Therefore, a
thorough investigation of the possible biopsychosocial indicators of eating disorders is
necessary.

Eating Disorder Risk Factors
Anorexia and bulimia share some general risk factors but are also unique and
distinct illnesses. Both eating disorders have gender as their most potent risk factor; being
female places one at much higher risk than being male (Southgate, Tchanturia, &
Treasure, 2005). Numerous characteristics developed during childhood also place one at
higher risk for developing an eating disorder, such as traits on the obsessive compulsive
disorder spectrum or a tendency to internalize events. Certain temperamental traits are
also highly correlated with eating disorder onset such as compulsivity, characterized by a
fear of mistakes, perfectionism or rigidity, and emotionality, characterized by neuroticism
and behavioral inhibition (i.e., shyness and social anxiety; Anderluh, Tchanturia, RabeHesketh, & Treasure, 2003). Risk factors unique to each disorder tend to include
appetitive behaviors and body weight. Individuals with anorexia tend to have a poor
appetite during childhood and a lower than average body weight, with the opposite being
true in individuals who have bulimia (Southgate et al., 2005). Individuals with bulimia
also tend to have more exposure to adverse events in their lives than do those with
anorexia.
Anorexia and bulimia appear to have similar factors that trigger the onset of the
illness. There tends to be some sort of nutritional stress, which can be the result of either
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a diet, exercise, or an illness that occurs in the context of some distressing life event
(Southgate et al., 2007). Maintenance of the disorders occurs through a variety of factors,
where the core operating structures appear to be specific to the type of eating disorder
developed. According to Schmidt and Treasure (2005), anorexia is maintained through
the effect of the illness on the individual’s interpersonal relationships as well as the
secondary gains resultant from the illness. Fairburn and colleagues (1993) developed a
maintenance model of bulimia. They found that self-esteem based on appraisals of weight
and shape feeds the inception of the illness. The illness is then maintained through cycles
of self-perpetuating behavior (i.e., binge/purge) that are intended to counteract low selfesteem but instead strengthen it. Figure 1 provides a working model, developed by
Southgate et al. (2005), of eating disorder development and maintenance.

Underlying Neurological and Biological Factors Support a Disruption in
Collaborative Brain Function
Anorexia presents as a unique physiological condition, quite different from
bulimia. Investigative studies using functional magnetic resonance imaging found
neuronal abnormalities that appear to be specific to anorexia. These abnormalities include
decreased brain volume (Katzman et al., 1996), diminished cerebral blood flow and
metabolism (Delvenne et al., 1995), disturbances in event-related potentials (Bradley et
al., 1997), impaired cognitive performance on tests (Green, Elliman, Wakeling, &
Rogers, 1996) and altered levels of neurotransmitters (Kaye et al., 1998). These
abnormalities suggest a physical neural mechanism underlying anorexia. Interestingly,
Uher et al. (2003) found differences in the neural correlations of individuals suffering
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Figure 1. Proposed Model of Biopsychosocial Eating Disorder
Inception and Maintenance (Southgate et al., 2005).

9

from chronic anorexia and individuals who had been recovered from anorexia for a
minimum of two years. These observed differences may represent changes in brain
behavior that occurred with the treatment and recovery process; in particular, they may
represent changes in information and/or cognitive processes.
While bulimia does not trend toward the chronic course presented by anorexia,
changes in the central nervous system are observed in the disease. For example, during
the course of the illness, regional blood flow to the inferior frontal and left temporal
cortical areas is elevated (Nozoe et al., 1995). It has been posited that these two areas
play a significant role in the pathophysiology of bulimia. Cerebral blood flood is
suggested to vary as a function of bulimia’s restricting and binge/purge phases (Hirano et
al., 1999). Cerebral blood flow correlates with glucose metabolism, which relegates a
correlation of alterations in blood glucose levels to bulimia (Fox et al., 1988). Frank et al.
(2000) examined the activity of cerebral blood flow in recovered bulimic individuals and
found no significant difference from the control subjects. This supports the idea that
elevated cerebral blood flow in bulimic individuals is inclusive of their pathophysiology.
Upon recovery, cerebral blood flow will return to that of a non-eating disordered
individual. This suggests that effective treatment and subsequent recovery should return
some of the abnormal brain functions associated with bulimia to a more normalized level.
The unique presentation of these two disorders encourages further investigation
into the role of neurotransmitters, cerebral blood flow, and other neurological
foundations. Theories incorporating the inner workings of the brain could help to
elucidate some of the unknown aspects of these disorders as well as allow for the
development of new hypotheses in how to best treat and/or measure eating disorders.
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The brain is composed of highly concentrated overlapping neural networks
involved in the acts of desiring, seeking out, obtaining, and consuming foods. The
ventromedial hypothalamus and nucleus accumbens are both highly implicated in these
networks. The nucleus accumbens, in particular, is recognized as the major reward center
of the brain. This nucleus is modulated by numerous neurotransmitters including
dopamine, glutamate, and opioid neuropeptides (Simansky, 2005). Addiction research
shows that stimulating these neural pathways and neurotransmitters may lead to
physiological and behavioral pathology often combined with cravings, obsession, and
overconsumption.
Dopamine action in the nucleus accumbens is of particular interest in addiction
research. Some eating disorder theorists suggest that self-administration of substances
and feeding behaviors can be considered in the same category as substance or alcohol
abuse due to similarities in animal behavior with self-administration of these substances
(Wise, 1997). One study found that both food deprivation (mimicking anorexia) and
overeating (mimicking binge-eating) increased dopamine activity in the lateral
hypothalamus, which led to increased activation in the nucleus accumbens. This
behavioral effect is similar to the activation seen when rats lever-press for electrical
stimulation of their medial forebrain bundle, of which both the lateral hypothalamus and
nucleus accumbens are a part (Hernandez & Hoebel, 1988). In light of these findings,
Davis and Woodside (2002) examined the role of anhedonia in individuals with eating
disorders. They reported that anorexic individuals had significantly higher levels of
anhedonia compared to bulimic individuals. Anhedonia, a diminished ability to
experience pleasure, stems from dopamine interaction with the mesolimbic structures
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making up the reward pathway. This finding suggests that the compulsive and addictive
nature of anorexia may have roots in decreased dopamine activity in the reward centers of
the brain. As previously mentioned, food deprivation does increase levels of dopamine in
the medial forebrain bundle, demonstrating that the anorexic may be behaviorally selfmedicating for this deficiency.
Some theorists claim that eating-disordered behaviors present with the same
characteristics as the auto-addiction opioid theory. This theory, commonly used to
describe addiction, proposes that behaviors are undertaken, such as starving or
overexercising, to increase the levels of ß-endorphins in the body. These ß-endorphins are
biologically identical to exogenous opioids; thus, these behaviors take on an addictive
quality due to their ability to stimulate the reward centers in the brain (Marrazzi & Luby,
1986).
As previously mentioned, the brain is composed of a complex network of
neurotransmitter pathways with many neurotransmitters interacting at different levels.
Serotonin (5-HT) is the primary neurotransmitter implicated in eating disorder pathology.
Disturbances in 5-HT levels have long been implicated in eating disorder pathology. 5HT is implicated in a variety of psychopathologies commonly comorbid to eating
disorders. For example, 5-HT has been implicated in personality and temperament traits
such as behavioral inhibition, harm avoidance, and borderline personality disorder (Paris,
Zweig-Frank, Kin, Schwartz, Steiger, & Nair, 2003). 5-HT is also implicated in
numerous psychiatric conditions such as anxiety, fear, obsession (Barr, Goodman, Price,
McDougle, & Charney, 1992), and depression (Grahame-Smith, 1992). Similarly,
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serotonin (5-HT) disturbances have long been documented in individuals with eating
disorders.
Research has found a significant negative correlation between eating-disordered
behaviors and 5-HT levels. This supports the idea that eating-disordered behavior serves
as a self-medication against high levels of anxiety. Kaye (1999) proposed that this is
because the eating-disordered behavior increases the level of 5-HT in an overactive 5-HT
system. Recovered bulimic individuals still exhibit disturbances in the 5-HT system, even
after long-term recovery (Kaye et al., 1999; Smith et al., 1999). Disturbances in these
neurotransmitters, amongst others, may play a large role in the etiology of an eating
disorder (Kaye, 1999). Finally, 5-HT plays a role in satiety after food consumption (King,
2006). A recent investigation by Kaye, Frank, Bailer, et al. (2006) reported disturbances
in 5-HT1A and 5-HT2A receptors as well as in the 5-HT transporter in anorexic and
bulimic individuals. These disturbances are reported over the long term in individuals
who were previously ill and recovered from anorexia or bulimia (Kaye et al., 1999; Smith
et al., 1999).
5-HT1A is purported to play a role in mood and impulse control, anxiety, feeding
behavior, and selective serotonin reuptake inhibitor (SSRI) response. Using positron
emission tomography (PET), Kaye et al. (2005) found increased receptor activity of 5HT1A in prefrontal, medial, and lateral orbital frontal, parietal, lateral temporal, and
supra- and pregenual cingulated regions, as well as in the dorsal raphe nuclei in recovered
anorexic-bulimic and bulimic individuals. These findings, again, exemplify the long-term
changes in 5-HT receptor activity in the brain. Recovered anorexics did not show a
significant difference in 5-HT1A receptor activity relative to control subjects, perhaps
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providing insight as to why bulimic individuals are responsive to SSRIs but anorexic
individuals are not. To date, increased 5-HT1A receptor activity has only been found in
individuals exhibiting bulimic symptomology.
The 5-HT2A receptor is implicated in the regulation of mood, anxiety,
antidepressant action, and feeding (Barnes & Sharp, 1999). Kaye et al. (2005) reported
reduced 5-HT2A receptor activity in the parietal, occipital, and subgenual cortex in both
recovered anorexic-bulimics and anorexics. Additionally, recovered anorexics showed
reduced 5-HT2A activity in the mesial temporal region and pregenual cingulate. Other
investigators reported a significant reduction in 5-HT2A receptor activity in the left
frontal cortex, the occipital cortex, and the parietal cortex in ill anorexics (Audenart et al.,
2003). Bulimics were found to have normal 5-HT2A activity (Goethals et al., 2004).
While these findings are consistent with the speculation of 5-HT2A disturbances in
anorexia, the disturbances of 5-HT2A in bulimia are less clear.
Research consistently shows disturbances in 5-HT1A and 5-HT2A receptor
activity in recovered eating-disordered individuals. Similarly, the disturbances in
dopamine (DA) activity in the brains of eating-disordered individuals are becoming well
documented. It is currently unknown whether neurotransmitter disturbances precede the
eating disorder or the eating disorder causes the disturbance, but the involvement of these
neurotransmitters in the eating disorder is evident. Evidence concerning the effect of
disturbances in synaptic pruning in adolescence and the dysregulation in the
hypothalamic-pituitary-adrenal axis (HPA axis) further support these hypotheses. Kaye et
al. (2005) hypothesized that eating-disordered individuals have a dysregulation in the
function of their neural circuitry, most likely relating to disturbances in any number of
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the components of the circuit. These disturbances could be in the form of interacting
receptors or in the molecules forming the intracellular communication translating the
receptor signals. While it is known that receptor activity is a combination of many factors
such as neuronal firing, exocytosis, reuptake, and other intracellular mechanisms, the
technology to pinpoint exactly where in this process the disturbance lies is still
unavailable. Part of the challenge facing the pharmaceutical community in creating
effective drugs to treat eating disorders is diagnosing how to best normalize the
disruption in neurotransmitter activity.

Neuropsychological Models of Brain Development and Their Impact on EDOs
There are currently numerous models of the potential vulnerabilities and risk
factors for eating disorders. The focus has recently moved toward the examination of the
neurological, genetic, and biological underpinnings of these disorders. Bulimia and
anorexia present with different underlying physiological mechanisms. These differences
may explain why anorexia and bulimia respond to psychopharmaceutical and therapeutic
interventions differently. For example, bulimia is generally more responsive to fluoxetine
than anorexia. Anorexia is more likely to be a chronic condition than bulimia.
Furthermore, numerous investigations found that individuals suffering from anorexia tend
to be repeatedly hospitalized (Keel & Klump, 2003; Milos et al., 2003).
One neurodevelopmental model of eating disorders relies on the HPA axis as a
primary mechanism underlying the chronic stress and maladaptive coping strategies seen
in individuals with eating disorders (Connan, Campbell, Katzman, Lightman, & Treasure,
2003). This model stresses the importance of genetic factors, childhood experiences, and
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the biopsychosocial environment in modifying the HPA axis. These alterations lead to
maladaptive cognitive, emotional, and social functioning. The HPA axis, along with its
control mechanisms located in the central nervous system, enables the metabolic
resources necessary for all of our behaviors (Lovallo & Thomas, 2005). Operating in all
stages of life, from sleep to severe stress, the HPA axis is also responsive to our private
emotions and thoughts. Research indicates that the HPA axis produces large stress
responses when exposed to novel stimuli but that with further exposure, these responses
decrease. Interestingly, though, Mason (1968) claimed that the stressfulness of a response
is not purely reflexive but is also modified by previous experience and the nature of the
environment.
This is important to consider in eating disorders because when an individual is
exposed to consistently traumatic experiences, the HPA axis is altered in response to the
high levels of glucocorticoids necessary to maintain a state of alertness (i.e., a state of
fight or flight). Over time, high levels of glucocorticoids damage the hippocampus,
impairing memory formation as well as affecting levels of epinephrine and cortisol.
These changes result in a disruption in the ability to maintain normal cognitive
functioning (Lovallo & Thomas, 2005). The HPA axis also plays a large role in the
regulation of 5-HT neurotransmitters, with chronic stress leading to decreases in
hippocampal 5-HT1a and 5-HT1b and an increase in cortical 5-HT2a. These changes, as
will be illuminated later, have been noted to be significant in individuals with an eating
disorder and are also highly correlated with suicidal behaviors (Lopez, Vazquez,
Chalmers, & Watson, 1997).
Adolescence is an extremely important time for brain development. During the
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adolescent years, the brain begins the process of synaptic pruning, resulting in the
elaborate branching-out of dendrites and increasing levels of myelination. Synaptic
pruning is associated with vital refinements to brain systems through increasing
efficiency and efficacy by removing redundant neural connections (Southgate et al.,
2005). Myelination allows for more rapid communication throughout the brain by
speeding up neural transmission. These changes allow for the collaboration of widely
dispersed circuitry throughout the brain and the integration of a variety of brain regions,
ultimately allowing top-down cognitive control of behavior (Luna & Sweeney, 2004).
The enhanced communication between areas of the brain such as the prefrontal cortex,
basal ganglia, thalamus, and frontal cortex set the stage for the maturation of the brain in
such a way that reflective and inhibitory processes are more consistent and efficient. This
stage of brain development in adolescence leads to the development of “collaborative
brain function.”
Synaptic pruning and the HPA axis are implicated as causal factors in developing
a vulnerability to an eating disorder. Southgate and colleagues (2005) proposed that
because of the alteration in the HPA axis, leading to a poor coping response to stress,
certain individuals are in a persistent state of intense and demanding emotional distress.
This state, when it persists through adolescence, interrupts the process of synaptic
pruning, thereby disrupting the brain’s transition from localized function to collaborative
brain function. Secondary effects commonly seen in eating disorders also play a role in
disrupting this critical time of brain development. Poor nutrition eventually disturbs the
regular maturational processes of the brain and can also disrupt normal hormonal
changes. The effects of a lack of complete development of collaborative brain function
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can cause specific behaviors to arise that are often noted in an individual with an eating
disorder. For example, behavioral focus may be on internal or external stimuli that are
immediately gratifying or rewarding but may be harmful in the long run. The lack of
integrative brain function inhibits the top-down control of behavior and therefore may
lead to the preservation of maladaptive behaviors.

Role of the Social Information Processing Network in Eating Disorders (Nelson et
al., 2005)
The neurological underpinnings of an eating disorder play an important role in
how individuals with anorexia and bulimia interact with and perceive the world around
them. Nelson and colleagues (2005) introduced the social information processing
network (SIPN) to elucidate the variety of factors interacting to define how an individual
experiences the world. The SIPN is composed of cognitive, affective, and detection nodes
that mature during the process of synaptic pruning. During adolescence, the SIPN is
modulated by gonadal hormones. With the onset of puberty, changes in hormones impact
the cells in the affective node, thus affecting the intensity and valence of social stimuli. A
hypersensitivity to interpersonal relations is created and can lead to increased emotional
responsiveness in scenarios concerning self-esteem, acceptance, rejection, and motivation
(Southgate et al., 2005). Research has found eating disorders to often be triggered by
interpersonal problems, and it is possible that lack of maturation in the SIPN forms a
neural vulnerability in the affective realm that leaves one susceptible to eating-disordered
behavior.
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Researchers have recently begun investigating executive functioning in
individuals with eating disorders. Particular focus has been on inhibitory processing in
order to examine the role of impulsivity in individuals with anorexia and bulimia.
Congruent with the clinical presentation of individuals with anorexia, restricting subtype,
there are increased levels of inhibitory processing. Interestingly, individuals with bulimia
and those with anorexia, binge/purge subtype tend to have poorer inhibitory processing,
hinting at higher levels of impulsivity (Rubia, Smith, & Taylor, 2005). Numerous other
investigations into set-shifting abilities and cognitive flexibility consistently show deficits
in overall executive functioning. Individuals with eating disorders appear to be able to
inhibit or withhold the activation of new behaviors and may even have difficulty
beginning new behaviors but have an extremely difficult time disrupting or stopping
ongoing behaviors. From a wider perspective, these disorders can be conceptualized as
being composed of a continuous cycle of behaviors that is difficult to break, particularly
for individuals who have impediments in executive functioning.
Gillberg and colleagues (1996) suggested that individuals with anorexia struggle
with goal-directed behavior. Their research indicated that under certain circumstances,
individuals with anorexia will display a cognitive style that ultimately hampers task
completion. Goal directedness is characterized by an individual’s ability to take a step
back from the minute details and see the bigger picture. Individuals with anorexia tend to
have superior performance in attending to details and excelling in tasks requiring directed
effort than those with bulimia and nonclinical controls. On the other side of this cognitive
continuum, individuals with anorexia tend to have very weak performance with respect to
incidental learning. Frith (1989) labeled this cognitive style “weak central coherence” in
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which these individuals persist on focusing on details even when the instructions of the
task at hand call for global information processing. These behaviors are adaptive neither
for the task at hand nor for normal, healthy functioning. The cognitive style of an
individual with anorexia reflects an overwhelming tendency to use localized rather than
distributed information processing networks (Southgate et al., 2005). These findings,
again, reflect the importance of synaptic pruning during the adolescent’s development as
well as the impact of a dysregulated HPA axis.
It has long been accepted that individuals with eating disorders struggle with
emotional experiences, expression, and regulation (Kucharska-Pietura, Nickolauo,
Marsiak, & Treasure, 2004; Schmidt, Jiwany, & Treasure, 1993; Zonnevylle-Bendek, van
Goozen, Cohen-Kettenis, van Elburg, de Windt, & Stevelmans, 2004; ZonnevylleBendek, van Goozen, Cohen-Kettenis, van Elburg, & van Engleand, 2002). Individuals
with eating disorders also tend to have comorbid alexithymia, suggesting poor emotional
intelligence. Furthermore, Friederlich and colleagues (2005) found a disturbance in the
emotional processing of pleasant stimuli using a startle eye blink paradigm. Both
anorexics and bulimics failed to show the activation in the appetitive-motivational system
that control subjects portrayed when shown positive stimuli. Anorexics tend to also have
further emotional dysregulation that becomes a pervasive form of anhedonia and disrupts
their internal reward system, therefore limiting or completely eliminating their experience
of pleasure (Davis & Woodside, 2002).
Animal studies have evidenced that lesions in the ventral striatum, which includes
the nucleus accumbens, block response to the startle reflex in positive states (Koch,
Schmid, & Schnitzler, 1996), as does destroying dopaminergic neurons in this same

20

region. This information becomes important when one is considering the role of the
dopamine systems in eating disorders. Impaired dopamine function is found in both
bulimic and anorexic individuals. Individuals who have recovered from anorexia still
display increased D2/D3 receptor binding in the antero-ventral striatum (Frank et al.,
2005). These abnormalities may be responsible for the low appetitive drive and general
anhedonic response seen in individuals with anorexia. Contrastingly, individuals with
bulimia portray reduced D2/D3 binding in the antero-ventral striatum, similar to what is
noted in individuals with substance abuse (Wang, Volkow, Logan, et al., 2004). Such
neurological deficiencies and cognitive dysfunctions inevitably impact individuals’
perception of the world around them.

Social and Cultural Factors in Eating Disorder Development and Maintenance
After a review of the literature, Smolak and Levine (2006) reported strong
evidence suggesting that weight concerns, dieting, and body dissatisfaction predict the
inception of eating pathology. Interestingly, a large meta-analysis performed by Keel and
Klump (2003) found evidence suggesting that bulimia is a culture-bound syndrome,
while anorexia is not (although cultural influences are found to aid in the maintenance of
anorexia). The results of both of these investigations hint at the important role of societal
and cultural influences in eating disorders. In light of these findings, it is unsurprising
that new hypotheses regarding the roles of societal and cultural factors in eating disorder
conceptualization are gaining momentum. Two newer hypotheses, the eating disorder
continuum hypothesis and social cognitive theory, offer a viable beginning for the
conceptualization of eating disorder etiology.
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The eating disorder continuum hypothesis is based on the concept that disturbed
eating behaviors are a matter of degree (Scarano & Kalodner-Martin, 1994; Tylka &
Subich, 1999). It places unrestrained (or asymptomatic eating) at one end of the
continuum and clinical eating disorders (or anorexia/bulimia) at the other end of the
continuum. Between the two endpoints lie milder forms of disordered eating. Literature
supports the hypothesis that certain characteristics of clinical eating disorders align
themselves with the eating disorder continuum hypothesis. Because a majority of women
divulge the use of unhealthy eating behaviors and suffer psychological and physiological
consequences as a result, numerous clinicians have suggested that eating disorders ought
to be conceptualized on a continuum (Scarano & Kalodner-Martin, 1994; Tylka &
Subich, 1999). These clinicians note that examining different levels of eating disturbance
may illuminate etiological factors involved in the development and treatment of eating
disorders (Tylka & Subich, 1999). The eating disorder continuum hypothesis also sheds
light on the role of social-cultural factors in eating disorders.
Scarano and Kalodner-Martin (1994) reported that women who exhibit various
eating disturbances have similar psychological and behavioral characteristics as
individuals with eating disorders, differing only in terms of severity. For example, body
dissatisfaction, feeling fat, food preoccupation, weight preoccupation, and the fear of
becoming fat increase as an individual’s level of disturbed eating increases. Quantitative
differences have been similarly noted between subjects occupied with clinical,
subclinical, and unrestrained eating in the areas of interoceptive awareness, interpersonal
relationships, and feelings of ineffectiveness; difficulties in these arenas increase as
disturbed eating behaviors increase. More recently, Tylka and Subich (1999) examined
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personality and cognitive facets commonly found in eating disorders along the eating
disorder continuum. Their study further highlighted the differences between the
asymptomatic, symptomatic, and eating disorder continuum groups, finding a linear
relationship amongst the three groups. Similarly, they found a linear relationship with
internal dieting locus of control and internalization of the thin-ideal stereotype (Figure 2).
In light of the large influence of society, culture, and the continuum of eating
disorder pathology, it is important to examine the role of the environment in the
development of an eating disorder. For example, Becker et al. (2002) assessed the effect
of the introduction of television on disordered eating behaviors in a Fijian population
with no previous media exposure. With the introduction of television to this culture,
disordered eating behaviors and attitudes rose significantly. This investigation provides a
clear indicator of the negative impact of television, especially in influencing body-image

Figure 2. Likelihood of a Diet Progressing Into an Eating Disorder.

23

schemas (Figure 3). Nichter and Nichter (1991) asked adolescent girls to describe their
ideal female form. The girls significantly endorsed a female who was 5 ft 7 inches, 100
lbs, and a size 5. The Body Mass Index (BMI) for their idealized female is 15.61, hugely
below the recommended minimum weight of 118 lbs (BMI 18.5) for someone who is 5 ft
7 inches. The idealized female described by these adolescents would easily meet criteria
for anorexia. Clearly, a normal adolescent girl cannot healthfully fit this idealized model.
Yet according to this study, it is one of the main factors in the social status quo among
adolescent females.
The discrepancy between girls’ true forms and the idealized form may play a
significant role in their self-perception (Levine & Smolak, 1998; Smolak & Levine,
1996). The more importance placed on this discrepancy, the larger the tendency toward
eating-disordered behavior. Correspondingly, some researchers have proposed that the
pressure to be thin influences two variables core to creating eating-disordered behavior:
the internalization of the thin ideal and disturbance in body image (Stice, Nemeroff, &
Shaw, 1996). Because the standard of thinness promoted by society is impossible for
most women to achieve, they are left feeling negative about their own bodies. This
negativity results in more body-image disturbance. As Frederickson and Roberts (1997)
pointed out, women in America are often socially conditioned to base their sense of selfworth on their appearance. It is now considered normative for women to have a moderate
degree of body dissatisfaction and to use diet and exercise to manipulate their weight and
body in an attempt to conform to the portrayed media ideal (Gordon, 2000).
An overwhelming amount of evidence suggests that many of the factors involved in the
maintenance of an eating disorder are learned behaviors (Smolak & Levine, 2006).
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Figure 3. Body Satisfaction in American Women
After Viewing Media Images.

Because of the apparent role of modeled and learned behaviors in eating disorder
pathology, numerous researchers are now ascribing to a sociocultural model of eatingdisorder conceptualization based on social cognitive theory (SCT; Bandura, 1986). SCT
views behavior as the result of transactions between three factors: (a) an individual’s
cognitive and emotional processes; (b) patterns of behavior and competencies; and (c) the
context or environment. The compilation of these three factors creates the learned
behaviors and cognitions through which an individual navigates the world, known as an
individual’s schema. A schema represents the mental structures that help people manage
their interactions with the environment in consistent, stable, and meaningful ways (Solso,
MacLin, & MacLin, 2005).
Research on eating disorders supports the three factors of SCT in its
conceptualization of eating disorder pathology. For example, Frederickson and Roberts
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(1997) suggest that women are socialized to equate self-worth with their appearance. This
objectification of themselves is the result of psychological variables working in
conjunction with sociocultural factors, leading to body shame and body-image
disturbance. Similarly, it has been suggested that pressures to be thin are predictive of
negative affect and poor social support in women (Maine, 2000; Pipher, 1994;
Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999). Research utilizing the eating
disorder continuum hypothesis supports these suggestions. Stice et al. (1996) found that
pressure to be thin predicts the unique variance in body dissatisfaction, even beyond the
variance accounted for in the internalizing of the stereotypical thin ideal.
It is important to note that while the environment and culture may have a strong
impact on eating disorder inception and maintenance, they have only an indirect
relationship with actual eating disorder psychopathology. The other two factors of SCT,
an individual’s cognitive and emotional processes and patterns of behavior, also play a
key role in an eating disorder’s etiology. While each of the three factors of SCT has a role
in eating-disordered behavior and pathology, the result is a specific type of schema
present in eating-disordered individuals (Levine & Smolak, 2006). This schema, called a
body image schema, organizes various mechanisms of body image such as shape, weight,
appearance, and health (Smolak & Levine, 2006). The body image schema is the result of
the interplay of SCT factors, particularly highlighting experiences and cognitions around
teasing, mass media, standards of beauty, and the thin ideal in the individual’s
environment. The prevalence of the expectations and ideals in westernized cultures and
societies support the role of the sociocultural model of eating disorders in the eating
disorder continuum model hypothesis. The schema is not necessarily applied to every
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interaction an individual has, but it is activated in many normal, everyday interactions
such as looking in the mirror, meeting someone new for the first time, shopping for new
clothes, being presented with certain foods, and/or spending time with friends.
The activation of the body image schema results in internal dialogues involving
personal interpretations, thoughts, and conclusions about different interactions and
situations (Cash, 1997). For someone with a negative body image schema, this internal
dialogue represents a disparity between an investment in the value of a thinner shape or
lower weight and an individual’s self-perception. This disparity is often seen in
individuals who are at risk for disordered eating (Smolak & Levine, 2006)—hence the
application of SCT to eating-disorder conceptualization. Ainsworth, Waller, and Kennedy
(2002) suggested that bulimic behaviors were often engaged in order to “block” the
aversive body image schema. Similarly, Stein and Corte (2003) argued that a disturbed
body image motivates eating, body, and weight attitudes characterizing both anorexia and
bulimia. They also found that women with a negative body image schema and few
positive self-concepts were more vulnerable to societal commentary about food and body
concerns as well as the thin ideal. This further supports the strong impact of cultural and
societal ideals.
One of the key roles of the body image schema in eating-disorder maintenance is
that it creates a cyclical and self-reinforcing thought process (Smolak & Levine, 2006).
The bias inherent in the negative body image schema controls individuals’ everyday
interactions with the world and themselves. Behaviors resulting from the thought
processes wrapped up in the schema often lessen the immediate negative affect attached
to the schema but have the long-term consequence of further strengthening the bias
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(Smolak & Levine, 2006). The result of this cycle is the acquisition of eating-disordered
pathology in a previously vulnerable individual or the worsening of pathology in an
already-afflicted individual.
Tylka and Subich (2004) suggested five variables active in eating disorder
vulnerability. The higher an individual’s loading on these factors, the more apt he or she
is to have eating-disordered behaviors or pathology. The five factors are (a) body image
disturbance, (b) the internalization of the thin ideal, (c) poor family social support, (d)
poor friend social support, and (e) negative affect. Tylka and Subich’s model brings
together not only the environmental and cultural influence of the pressure to be thin, but
also personal and social variables. The model is a more precise examination of the SCT
model for eating-disorder conceptualization. This model also lends credence to the eating
disorder continuum hypothesis by illuminating the fact that not all individuals will have
strong loadings on all five variables.
The primary predictor of eating disorder symptomology is body-image
disturbance (Phelps, Johnston, & Augustyniak, 1999). Researchers have long accepted
the role of body-image disturbance in eating disorder etiology (Frederickson & Roberts,
1997; Stice et al., 1996; Thompson et al., 1995; Tylka & Subich, 2004). Numerous
studies indicate that individuals who have more body image disturbance are more likely
to attempt to modify their bodies through the use of maladaptive weight-control
techniques. Furthermore, higher levels of disturbed body image are negatively correlated
with the ability to identify emotions as well as hunger and satiety signals (i.e.,
interoceptive awareness). Frederickson and Roberts (1997) suggested that the decrease in
interoceptive awareness is due to the shame an individual feels when he or she has body-
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image disturbance. This shame leads the individual to suppress hunger and satiety cues in
order to lose weight or otherwise attempt to change his or her body.
Negative affect presents as both neuroticism and low self-esteem in individuals
with disordered eating or eating disorders (Tylka & Subich, 2004). Negative affect
accounts for many of the smaller variables making up the personal affective and
cognitive aspect of SCT. For example, in Tylka and Subich’s model, negative affect
subsumes many other variables related to eating disturbances such as anxiety, depression,
lack of impulse control, maladaptive coping, and irrational cognitions. Low self-esteem
plays a large role in negative affect and is highly predictive of future eating disorder
symptomology. Some theorists propose that negative affect is the key predisposing factor
to internalizing the thin-ideal stereotype (Thompson et al., 1999). Furthermore, negative
affect has a key role in the disturbed interoceptive awareness experienced by individuals
with eating disorders. The lack of interoceptive awareness is not only related to the
avoidance of hunger and satiety cues but, as Tylka and Subich (2004) have suggested,
also related to the avoidance of all internal states including emotions. This suggestion has
been supported in examination of the eating disorder continuum hypothesis in high
school- and college-aged women (Pike, 1995; Tylka & Subich, 1999). Similarly, Mazzeo
and Espelage (2002) reported that alexithymia, the inability to describe emotions
verbally, is also a unique predictor of some eating-disorder variance.
Body-image disturbance and negative affect are at the core of the body-image
schema. Intertwining these two components leads to a clear vulnerability to eatingdisordered symptomology. When other variables such as poor relational or social support
factors, genetic factors, and issues relating to trauma are heightened in certain
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individuals, their predisposition toward having an eating disorder similarly is heightened.
This conceptualization points to a diathesis-stress model for eating disorders. The eating
disorder continuum model, in particular, supports a diathesis stress etiology, and it is
further illuminated by the concepts set forth in SCT, in the body image schema, and
ultimately in Tylka and Subich’s (2004) multidimensional model of eating disorders.
Thus far, research has indicated that individuals with eating disorders exhibit
dysfunctional emotional processing. This dysfunction appears to be correlated with
appetitive responses generally related to the dopaminergic systems and reward pathways.
Synaptic pruning and disturbances in the HPA axis also appear to play a role in the
disruption of the development of collaborative brain function as well as an individual’s
ability to handle stress in an adaptive way. The combination of these factors hints at
neurological underpinnings that are suggestive not only of potential vulnerability to
acquiring an eating disorder, but also, almost certainly, of risk factors in both the onset
and the maintenance of an eating disorder. These neurological vulnerabilities combine to
create a biological environment susceptible to the pressures of western society. Today’s
world is rich with pressures that aid in both the development and maintenance of eatingdisordered thoughts and behaviors. Clearly, effective treatment for an eating disorder
must target a myriad of variables, often unique to each patient.

Treatment of Eating Disorders
The treatment of such multifaceted and unique disorders has challenged the health
care community for decades, if not centuries. The social, cultural, neurological, and
biological risk factors and vulnerabilities explored thus far are just the tip of the iceberg.
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Treatment response can be just as varied as the symptom presentation of these disorders.
Thus far, this review has highlighted the importance of both the affective and the
cognitive nodes of the social information processing network (SIPN; Nelson et al., 2005);
the possibility of intense emotional dysregulation and impulsivity in individuals with
bulimia, binge/purge subtype; as well as the inhibitory, detail-focused processes of
individuals with anorexia. Treatment clearly needs to address all of these concerns, be it
through pharmacotherapy, psychotherapy, or a combination approach. Studies
investigating the use of pharmacotherapy in lieu of psychotherapy find it less effective,
with the greatest rates of success seen when antidepressants are paired with
psychotherapy.

Psychopharmaceutical Treatment of Eating Disorders
Anorexia and bulimia present a decades-long challenge to the psychiatric
community. Since their emergence as a significant clinical entity, numerous studies have
largely resulted in a knowledge base consisting more of “what not to do” than “what we
should do” for treatment. A variety of medication trials have been performed with reports
in the literature ranging from case reports of a few patients to the occasional doubleblind, randomized, controlled trial. So far, only fluoxetine has received U.S. Food and
Drug Administration (FDA) approval for the treatment of bulimia. There is currently no
FDA-approved drug for the treatment of anorexia, although fluoxetine was found useful
in the maintenance of recovery for anorexia (Holtkamp et al., 2005).
The lack of medications in the treatment of eating disorders remains a serious
concern due to the continued difficulty in treating these patients and the high morbidity
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and mortality rates resulting from them. Treatment is often costly and slow, with
estimates of length of recovery ranging from 57 to 79 months (APA Work Group on
Eating Disorders, 2000). A review of early studies using psychopharmacotherapy to treat
eating disorders demonstrates a focus on the most serious and acute manifestations
including malnutrition or weight loss and binge/purge cycles. Unfortunately, decades of
research using weight gain and decreased binge/purge cycles as primary outcome
measures in medication trials have provided few treatment options for either illness
(Krüger & Kennedy, 2000). Although this may also be related to difficulties of studying
this patient population, treatment providers are left sorely lacking tools to assist in the
treatment of these serious and potentially lethal mental illnesses.
Bulimia has the best developed treatment literature for psychopharmacology.
Studies have mainly focused on the use of selective serotonin reuptake inhibitors (SSRIs)
for treatment, although anticonvulsants, opiate antagonists, serotonergic agonists, and
lithium have been investigated for efficacy as well (Mitchell, de Zwann, & Roerig, 2003).
Bulimic individuals tend to respond best to antidepressants, particularly SSRIs. This
treatment results in significant reductions in eating-disordered behaviors such as binge
eating and purging. Not surprisingly, these antidepressants also decrease comorbid
psychopathologies such as anxiety disorders and affective disorder symptoms. As
previously mentioned, fluoxetine is the only FDA-approved medication for the treatment
of bulimia. In light of this, it has received the most attention in terms of research. One
seminal research study examined patient response to fluoxetine, at 20 mg/day or 60
mg/day, as compared to a placebo. The higher dose of fluoxetine was reported to be
visibly superior to the placebo (Fluoxetine Bulimia Collaborative Study Group, 1992).
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A few small studies have examined the use of other medications as offlabel treatment for bulimia. Topiramate, an anticonvulsant that is proposed to work on
voltage-gated sodium channels, glutamate receptors, and gamma-Aminobutyric Acid
(GABA) receptors, has shown some efficacy with bulimic patients (Zhu & Walsh, 2002).
A case study by Knable (2001) reported a significant decrease in the patient’s weight
concern as well as a significant decrease in her desire to binge, purge, and self-mutilate
following the use of topirimate to treat her epilepsy. Much more research is clearly
needed before efficacy can be claimed for the treatment of bulimia with this medication.
So far, only two studies have examined the use of opiate antagonists for bulimia
(Alger, Schwalbers, Bigaouette, Michalek, & Howard, 1991; Mitchell et al., 1989). Both
studies focused on the use of naltrexone, a drug commonly prescribed to help alcoholics
stop craving alcohol, in purging bulimics. Naltrexone is a competitive antagonist at the
mu-opioid and kappa-opioid receptors and thus modulates the dopaminergic mesolimbic
pathway affecting opiate receptors. The ineffectiveness found with naltrexone for the
treatment of bulimia is not surprising considering the findings of Davis and Woodside
(2002), who reported significantly less dopaminergic involvement for the purging
bulimic than for the anorexic or other subtypes of the bulimic spectrum such as
compulsive overexercisers.
Current literature has a dearth of studies examining the long-term efficacy of
antidepressants on bulimia. This is particularly concerning in light of the aforementioned
long-term disturbances in serotonergic activity in the brain. Another concern is the lack
of research examining the different subtypes of bulimia. Current research on bulimia
typically focuses on the prototypical purging subtype. Exercising bulimics portray
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different DA activity than do purging bulimics. These differences may affect the efficacy
of a drug on different bulimic subtypes.
Psychopharmacology for anorexia initially focused on SSRIs, with some efficacy
being seen with them for relapse prevention in weight-restored anorexics (Holtkamp,
2005). A large variety of pharmacotherapy options have been explored with the anorexic
population such as antipsychotics, narcotic antagonists, antihistamines, lithium, zinc,
antidepressants, and tetrahydrocannabinol (THC; Attria & Schroeder, 2005; Mitchell et
al., 2003). New research on the psychopharmacology of anorexia has focused on atypical
neuroleptics in order to better address the resistance to treatment commonly seen in
anorexia. The most difficult part of treating an anorexic patient is that such patients
present with two very serious concerns: the psychopathology of an anorexic and the
physiological attributes of a person close to emaciation presenting with symptoms such as
osteoporosis and amenorrhea (Mitchell et al., 2003). Separating the immediate
physiological concerns from the psychological concerns can be difficult to treat
psychopharmacologically. As the anorexic individual is restored to a healthy weight, he
or she may present with very different biological patterns and thus have different
responses to medications.
Typical pharmacotherapy for the acute anorexic focuses on medications designed
to induce weight gain such as antidepressants, lithium, and anticonvulsants. Treatment
trials with this methodology are not proven to have long-term efficacy. Use of SSRIs in
the treatment of acute anorexia also has limited results. Attia and Schroeder (2005)
reported no benefit of fluoxetine use in inpatient anorexics as compared to placebo. They
hypothesized that underweight anorexics may have neurochemical disturbances
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disrupting the drugs' mechanism of action, specifically disturbed 5-HT function.
Problematically for this hypothesis, 5-HT disturbance appears to remain in anorexic
individuals even after recovery (Kaye et al., 2005). The purported inaction of SSRIs on
the acute anorexic may be caused by an unknown mediating factor, perhaps the body’s
physical state. Interestingly, fluoxetine is reported as effective in weight maintenance as
it is in weight restoration, although results are still inconclusive (Kaye et al., 1999).
Numerous other medications are used to induce weight gain in the anorexic
individual. The opiate antagonists naloxone and naltrexone both result in consistent
weight gain in underweight anorexics. A randomized, placebo-controlled, double-blind
study on anorexics using naltrexone similarly reported significant improvement in eatingdisordered behaviors such as binge-eating and purging (Marrazzi, 1995). These findings
offer further support for the autoaddiction opioid theory of anorexia and should prompt
future investigation into an addiction model of anorexia. A small study of lithium
reported short-term weight gain in an anorexic population, but additional research is
needed (Gross, Ebert, Faden, et al., 1981). Because of its appetite-stimulating effects,
THC was examined in an anorexic population. No benefit of weight gain was seen, and
several participants dropped out of the study due to the side effects of the THC such as
paranoia, interpersonal sensitivity, and sleep disturbance (Gross, Ebert, Faden, et al.,
1983). Use of THC is this population was not shown to be efficacious.
Finally, antipsychotics have been heavily examined in the anorexic population
with studies dating as far back as the 1960s. Initial studies did show enhanced weight
gain, particularly on chlorpromazine, but participants displayed negative side effects such
as seizures and increased purging (Attia & Schroeder, 2005). Pimozide was also
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examined in an anorexic population, and although it did result in weight gain, there was
no improvement in patient behaviors or attitudes. Due to the significant negative side
effects and the minimal clinical efficacy of the traditional antipsychotics, they have not
been considered for mainstream anorexic treatment. The new atypical antipsychotics
present a new option for eating disorder clinicians due to their more manageable side
effects. In particular, olanzapine has been examined in several studies. It is currently
associated with some behavioral and psychological improvement as well as improved
weight gain (La Vie, Kaye, & Grey, 2000; Powers, Santana, & Bannon, 2002). Clinical
trials are needed to further support the efficacy of this medication for anorexia.
Most treatment practitioners working in the field of eating disorders recognize the
benefit of a combined pharmacotherapeutic and psychotherapeutic approach to treating
these multifaceted disorders. A review completed by Shapiro and colleagues (2007)
found only six studies examining the combined effects of pharmacotherapy and
psychotherapy in the treatment of bulimia. Combined treatment was associated with a
greater decrease in both binge and purge behaviors (Goldbloom, Olsted, Davis, et al.,
1997; Walsh, Wilson, Loeb, et al., 1997). Combined treatment studies for anorexia are
few and far between, with neither pharmacotherapy nor psychotherapy showing
consistent positive outcomes. The numerous factors neurologically, socially, culturally,
cognitively, and biologically account for the difficulty in finding successful treatment
strategies for both bulimia and anorexia. To date, a myriad of different approaches are
used psychotherapeutically to treat these disorders.
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Psychotherapeutic Models for the Treatment of Eating Disorders
Seven primary treatment models for eating disorders are commonly used today.
They are (a) psychodynamic therapy, (b) cognitive behavioral therapy (CBT), (c)
enhanced cognitive behavioral therapy (eCBT), (d) integrative cognitive-affective
therapy (ICAT), (e) interpersonal therapy (IPT), (f) dialectical behavioral therapy (DBT),
and (g) the addiction model.
Psychodynamic psychotherapy is one of the oldest and most respected forms of
treatment for mental illness. The psychodynamic philosophy places emphasis on internal
conflicts and motives as well as unconscious forces. Through this focus on unconscious
motives and conflicts, therapists are able to help the patient decipher the root causes of
their behaviors (Trull & Phares, 2001). While there are numerous psychodynamic
theories, such as self psychology and object relations, the underlying core concept of
treatment does not vary significantly. The underlying approach of psychodynamic
therapies is that underlying causes for disordered behaviors must be addressed and
resolved or else the behavior will continue to return. While traditional psychodynamic
views of maladaptive food behaviors were fixated on the sexual nature and interpretation
of the individual’s relationship to food, modern psychodynamic practitioners in the field
of eating disorders have a distinctly different view of maladaptive food behaviors
(Furumoto & Keating, 1995).
Modern psychodynamic theorists posit that adaptive behaviors arise when
developmental needs are not met (Costin, 1999). Adaptive behaviors then function as
substitutes for the developmental deficits and protect the individual against resulting pain,
frustration, and/or anger. The primary difficulty with these adaptive behaviors is that they
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never become internalized, as they do not have the ability to replace the behaviors needed
for healthy development. For individuals struggling with eating disorders, some of these
adaptive behaviors can go on to threaten long-term health and may even lead to death.
For example, an individual who was never taught to self-soothe may rely on food for
comfort and thus binge eat when distressed. Another common example is an individual
who never developed an internal locus of control. When all control in the individual’s life
is externalized, events may feel chaotic, and severe restriction and control of food may
provide an internal sense of stability and safety. Gabbard (2000) provided a
comprehensive summary of the multiple developmental deficits that an individual may
experience and how eating-disordered behavior may serve as adaptive behavior:
(1) a desperate attempt to be special, (2) an attack on the false sense of self
fostered by parental expectations, (3) an assertion of a nascent true self, (4) an
attack on a hostile maternal introjects viewed as equivalent to the body, (5) a
defense against greed and desire, (6) an effort to make others—rather than the
patient—feel greedy and helpless, (7) a defensive attempt to prevent
unmetabolized projections from the parents from entering the patient, and (8) an
escalating cry for help to shake the parents out of their self-absorption and make
them aware of the child’s suffering.
In the psychodynamic framework, symptoms are considered to be expressions of a
struggling inner self. For an individual with an eating disorder, this struggling inner self
is using the disordered eating and weight-control behaviors as the primary method of
expressing the underlying problems or issues. These symptoms, then, are actually the
only method of communication for the pain and anger that the individual has, and thus
efforts to take them away are avoided (Costin, 1999). Ultimately, once the individual has
learned to internally meet his or her needs and no longer struggles with his or her initial
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development deficits, the eating-disordered behaviors will no longer be necessary and
will subside on their own.
Regardless of the primary framework of the psychodynamic approach, the
primary goal in therapy is to help the patient gain insight into how his or her past,
personality, and personal relationships interact and how this interaction relates to the
eating disorder. While an understanding of these factors and their interplay is clearly
valuable to an individual with an eating disorder, the psychodynamic approach to treating
eating disorders has two problems. First, patients with eating disorders are often in such a
state of depression, starvation, and/or compulsivity that their ability to explore their
histories and interpersonal relationships is almost nonexistent. In consideration of this,
medical stability, suicidal tendencies, starvation, compulsive binging/purging, and other
harmful behaviors will have to be addressed before any psychodynamic work can
commence (Costin, 1999). Second, it may take years for the patient to come to a full
understanding and integration of the factors leading up to his or her eating disorder.
During this time, the individual’s harmful behaviors may persist or worsen. This second
concern calls for an intervention with more immediate benefits.
Cognitive behavioral therapy (CBT) is recognized as the most efficacious form of
treatment for bulimia and is often referred to as the Gold Standard (Fairburn, 2006).
Recently, the National Institute for Clinical Excellence (NICE) assigned CBT a grade of
A as an empirically supported treatment modality for bulimia. Despite these accolades,
40% of individuals with bulimia who complete CBT will have relapsed by a 60-week
follow-up (Fairburn, Cooper, Doll, O’Connor, Bohn, & Hawker, 2008). The primary
mechanism of action in CBT is to help the client identify and change maladaptive
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cognitions. Cognition is a mental perception or awareness of one’s world. Cognitions are
fundamental to an individual’s ability to navigate the world in a successful manner. They
provide algorithms and patterns that make sense of the overwhelming sensory experience
of daily life. Individuals who struggle with depression, low self-esteem, anxiety, and a
myriad of other life-disrupting conditions typically struggle with harmful, or maladaptive,
cognitions.
Individuals who struggle with eating disorders tend to have rather insidious
cognitions concerning their identity, body, food, and other concepts tied to the inception
and maintenance of an eating disorder. These maladaptive cognitions are held sacred
because they provide a sense of control and order to an otherwise chaotic universe
(Costin, 1999). Eating-disordered behaviors such as binge eating, food restriction,
purging, and overexercising are all products of beliefs, attitudes, and assumptions about
the meaning of body weight and eating. These beliefs, attitudes, and assumptions are
typically distorted and in extreme situations may lead to an eating disorder. One of the
primary jobs of a therapist, regardless of orientation, is to begin to address, challenge, and
change these disordered thought processes. As mentioned previously, this is the primary
mechanism of action for a CBT therapist.
Costin (1999) identified four primary functions that cognitive distortions serve for
an individual suffering from an eating disorder.
1. Cognitive distortions provide a sense of being in control and being safe.
Example: Cognitive distortions such as all-or-nothing thinking and extreme thinking
provide a strict system of rules concerning acceptable and forbidden foods. Costin
discussed one bulimic woman who allowed herself no fat in her diet. If she did
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happen to eat something with fat in it, then she felt as though she had “failed her
system” and would subsequently binge on all of the forbidden foods and then purge.
2. Cognitive distortions further reinforce the eating disorder as an integral part of the
person’s identity.
Example: Eating-disordered behaviors such as restriction, overexercising, and weight
issues make the person feel unique and special. The individual becomes identified to
others as an individual with an eating disorder and further internalizes this
identification until the individual does not know who he or she would be without the
eating disorder. The maladaptive thoughts and beliefs create the individual’s sense of
self.
3. Cognitive distortions enable the individual to replace reality with a system that
supports the individual and allows him or her to rationalize his or her behaviors.
Example: Individuals struggling with an eating disorder use their distorted system of
rules to create a safe world to navigate. Magically thinking that one’s worries will
disappear as long as one weighs only 78 pounds creates a system where the individual
focuses solely on obtaining the goal weight at the cost of any other indicators of
reality.
4. Cognitive distortions help provide a justification or explanation of the individual’s
behaviors to other people.
Example: Physiological maladies are often drawn upon as explanations as to why an
individual can’t and/or won’t eat. Allergies pertaining to sugar, dairy, wheat, and
other common ingredients are often created to explain an individual’s severe
restriction from a certain food group. Statements such as “I already ate” are meant to
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soothe concerned family and friends. For an individual struggling with an eating
disorder, “eating a meal” can be equivalent to eating a small handful of grapes or a
cup of air-popped popcorn.
As shown, cognitive distortions provide an insidious mechanism for the eating
disorder to infiltrate the core of a person’s sense of self. If these distortions are not
appropriately addressed, the distortions and the corresponding symptomatic behaviors
will persist.
Despite the reported therapeutic efficacy of these primary types of treatment for
eating disorders, they still result in disappointingly low rates of total remission. There are
only two major studies examining the efficacy of CBT. Rates of recovery stall around
40%. In a large study funded by the National Institute of Mental Health, recovery rates in
the intervention sample were 40% while the treatment-as-usual group saw recovery rates
of 29% (Agras et al., 2000). The McKnight Foundation found a recovery rate of 41% in
the intervention sample and 31% in the treatment-as-usual group (Mitchell, Halmi,
Wilson, Agras, Kraemer, et al., 2000). Due to the low rates of recovery, newer forms of
therapy are constantly being investigated for the treatment of eating disorders.
Fairburn, Cooper, and Shafran (2003) recently developed a form of CBT
specifically designed to treat individuals with eating disorders. This form of therapy,
called enhanced CBT (eCBT), includes the core premises of CBT while adding four
additional factors specific to the eating-disordered population. eCBT places a special
emphasis on interpersonal difficulties, clinical perfectionism, mood intolerance, and low
self-esteem. This form of treatment was designed for outpatient therapy and has two
treatment models. One is for an eating disorder patient with a BMI greater than 17.5; it
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takes 20 weeks to complete the entire sequence. The second sequence is for individuals
with a BMI lower than 17.5 and takes 40 weeks to complete. Fairborn et al. (2003)
devised a complete treatment strategy around four stages. The first stage incorporates
case formulation with early behavioral change. This stage is designed around biweekly
treatment sessions. The second stage reviews the case formulation and incorporates a
more in-depth intervention for the individual's problems in areas specific to the four
factors listed above. Stage 3 contains the majority of the treatment utilizing CBT
concepts but also includes modules specific to the four factors. Finally, during Stage 4,
the therapist works to help the individual devise a relapse prevention plan and encourage
the continuation of recovery. Results on the efficacy of eCBT are not yet available, as
Fairborn and colleagues are currently involved in a large study.
Another variation of the CBT paradigm is integrative cognitive-affective therapy
(Mitchell, Agras, & Wonderlich, 2007). This form of therapy emphasizes self-oriented
cognitions, interpersonal schemas, emotional experiences, interpersonal patterns, and
cultural experiences. Integrative cognitive-affective therapy is strongly based in
personality, attachment, and self-discrepancy theories. The theoretical background of this
theory is that individuals who suffer from bulimia experience a self-deficit between their
actual self and their ideal self. Due to this deficit, they develop an internal aversion to
their sense of self and corresponding negative affect. As they expect to be rejected for not
living up to the expectations of others, they develop maladaptive interpersonal patterns to
stave off abandonment and/or rejection. Similar to eCBT, this intervention is
conceptualized in four distinct phases. The first phase incorporates the first three sessions
of therapy. During this phase, the therapist focuses on increasing client motivation and
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psychoeducation. The second phase occurs over the next five sessions of therapy and is
focused on normalizing eating behaviors and helping the client develop coping skills.
Phase 3 spans Sessions 9 to 18 and contains the bulk of the work concerning
intrapersonal (cognitive) and interpersonal factors. In Phase 3, the therapist and client
focus on the primary factors, mentioned above, that make up the bulimic individual’s
pathology. Finally, Phase 4 focuses on the development of a maintenance and relapse
prevention plan.
Another primary form of therapy used to treat bulimia is interpersonal therapy
(IPT). IPT is based on the premise that interpersonal factors play a significant role in the
inception and maintenance of many disorders. It was originally developed as an
intervention for depression (Weissman & Markowitz, 1995). IPT for bulimia focuses on
four areas of interpersonal concern: interpersonal role disputes, interpersonal deficits, role
transitions, and grief (Jacobs, Robinson-Welch, & Wilfley, 2004). Typically, IPT engages
several therapeutic tools used to address these four areas, which include but are not
limited to communication training, feedback on problematic interactive patterns,
identification and exploration of feelings, and expectation modification. To date, IPT is
the only form of therapy that has outcomes comparable to those of CBT (Agras, Walsh,
Fairburn, Wilson, & Kraemer, 2000; Fairburn, Jones, Preveler, Hope, and O’Connor,
1993). Research suggests that this type of therapy may take longer to have an effect, as
end-of-treatment assessments are less favorable than those of CBT. Interestingly, at 1year follow-ups, the differences between individuals treated with CBT, as compared to
those treated with IPT, are insignificant. IPT therefore presents as a viable treatment
alternative for individuals with bulimia who are reluctant to engage in CBT or are
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struggling with interpersonal problems.
Dialectical behavioral therapy (DBT), pioneered by Marsha Linehan, has become
popular as a treatment choice for those struggling with an eating disorder. DBT was
originally designed to treat individuals suffering from borderline personality disorder
and/or struggling with suicidal and self-injurious behaviors (Linehan, 1993). The
methodology of DBT has since been modified for use in the treatment of eating disorders
and was shown to be effective in a small study conducted by Safer, Telch, and Agras
(2001). The treatment focus in DBT is behavioral change and strategies to help
individuals learn to accept themselves. The intervention is focused on the relationship
between the change process and self-acceptance. Linehan developed four skill modules
involved in skill acquisition: mindfulness, interpersonal effectiveness, emotion
regulation, and distress tolerance. Researchers hypothesize that DBT is effective in
treating bulimia because it targets the individual’s problems with emotion dysregulation,
which may be one of the core factors underlying bulimia (Mitchell et al., 2007).
Finally, some eating disorder practitioners use an addiction or disease model to
treat eating disorders. This model is also known as the abstinence model. This model is
adapted from the disease model of alcoholism (Rosenberg, Devine, & Rothrock, 1995;
Rosenberg & Rosen, 1994; Weisner, 1995). In this model, alcoholics are considered
powerless because the disease of alcoholism creates abnormal and addictive responses in
their body to the consumption of alcohol. Because of these abnormal and addictive
responses, the individual considers him- or herself to be powerless over the alcohol and
turns to a greater “power” for help. The Twelve Step program of Alcoholics Anonymous
was designed around this principle and is used worldwide to treat alcoholism. When
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practitioners apply this model to the treatment of eating disorders, they simply replace the
word “alcohol” with “eating disorder,” resulting in addiction support groups such
as Eating Disorders Anonymous (EDA) and, similarly, Overeaters Anonymous (OA).
The primary treatment approach of EDA and OA is to help the participant create and
maintain abstinence from foods that are considered to have addictive qualities, such as
sugar and white flour. As the participants work to gain and maintain abstinence from
these addictive foods, they work through the Twelve Steps of EDA.
The initial application of the addiction analogy of alcoholism to compulsive
overeating stems from the idea that if ingredients in alcohol could lead to an addictive
state, then certain foods might have the same effect. Despite the large numbers of
individuals utilizing the twelve-step model to help overcome their harmful relationship
with food, there is also no proof that the addiction model is a successful treatment model
for eating disorders or compulsive overeating (Costin, 1999). According to Hatsukami,
Owen, Pyle, and Mitchell (1982), the addiction model for the treatment of eating
disorders appears to have been readily adopted by practitioners due to the absolute dearth
of other treatment models. In 1993, the American Psychiatric Association (APA)
cautioned against the use of twelve-step models as the primary treatment for bulimia and
anorexia in their treatment guidelines for eating disorders. The APA stated concerns that
due to
the great variability of knowledge, attitudes, beliefs, and practices from chapter to
chapter and from sponsor to sponsor regarding eating disorders and their medical
and psychotherapeutic treatment and because of the great variability of patients’
personality structures, clinical conditions, and susceptibility to potentially counter
therapeutic practices, clinicians should carefully monitor patients’ experiences
with the Twelve Step programs. (APA, 1993)
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Psychotherapeutic Treatment Outcomes in Bulimia
In order to fully conceptualize the purpose and use of different treatment
modalities, it is important to define what recovery from bulimia is and the goal for
intervention. Typically, there are six primary objectives in the successful treatment of
bulimia (Mitchell et al., 2007). The first goal is to eliminate binge eating patterns and
compensatory behaviors. Second, the goal is to help the individual return to a normal and
healthy pattern of eating. Third, the importance of medical stability is taken into
consideration, and physical complications from the disorder are assessed. The fourth
objective is to address the underlying psychological concerns of the individual. This
typically includes addressing issues with self-esteem, interpersonal concerns, body image
dissatisfaction, and any other dysfunctional thought or behavioral patterns. Finally,
treatment must take into consideration comorbid conditions and address them effectively.
For example, it is quite common for individuals suffering from bulimia to have comorbid
diagnoses of depression and anxiety. The final objective of the treatment of bulimia is to
prevent relapse.
Literature on treatment modalities for bulimia is widespread. Since its original
description in 1979, a breadth of information regarding this disorder has developed.
Mitchell, Agras, and Wonderlich (2007) noted six main treatment modalities for bulimia
that are commonly used to treat this disorder. The first of these interventions has already
been discussed at length—psychopharmaceuticals. Optimal treatment results are seen
where there is a combination of psychopharmaceuticals and some form of psychotherapy.
The other five primary forms of treatment intervention for bulimia have already been
discussed. They are (a) cognitive behavioral therapy (CBT), (b) enhanced cognitive
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behavioral therapy (eCBT), (c) integrative cognitive-affective therapy (ICAT), (d)
interpersonal therapy (IPT), and (e) dialectical behavioral therapy (DBT).
Fairburn, Agras, Walsh, Wilson, and Stice (2004) found that the best predictor of
a good outcome at 8 months follow-up from treatment was an early reduction in purging
behavior. Unfortunately, there have been no studies supporting this as a positive outcome
variable 8 months posttreatment. Other researchers indicate that normalization in eating
patterns is a positive outcome predictor at 3 months posttreatment (Burton & Stice,
2006), but again there are no longer term follow-ups available. Clearly, while many
variables are hypothesized concerning the inception of, maintenance of, and recovery
from bulimia, none of these variables have been clearly indicated through research.
While a wide range of treatment strategies for bulimia exist, the effectiveness of
such strategies is low. Wilson (1996) and Agras (1993) maintained that recovery is only
achieved by about 50% of patients who enter treatment. Such low numbers prove that
further investigation into existing methods is needed. Complications with treatment are
often related to the difficulty in defining the etiology of eating disorders as well as the
role of societal and cultural factors. Researchers appear to have reached a consensus
regarding the importance of cognitions and interpersonal relationships in the maintenance
of bulimia. However, many clinicians and researchers also report reaching an impasse
when trying to identify which forms of therapy are most appropriate for each individual.
For example, Nevonen and Broberg (2006) suggested that IPT is more effective with
bulimic individuals struggling with impulsivity and affective instability, whereas CBT is
the treatment of choice for those whose EDO has an origin in body image, eating
concerns, and a focus on weight.
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Unfortunately, these aspects of an individual’s eating disorder may not emerge
until late in treatment. A recent factor analysis examining commonly used treatment
strategies for eating disorders reported that only 6% of respondents used a standardized
treatment manual, while 98% of the respondents used an eclectic methodology combining
strategies of all seven treatment methods described above (Tobin, Banker, Weisberg, &
Bowers, 2007). Empirically validated outcome strategies are almost impossible to assess
in such a varied and diverse treatment arena. Thus far, current research has only focused
on outcome data, which merely highlight success or failure in treatment.

Psychotherapeutic Treatment Outcomes in Anorexia
The treatment of anorexia suffers from much darker outcome results than bulimia.
Longitudinal studies on anorexia report high mortality rates. Studies with follow-ups
completed 5 to 10 years after treatment report mortality rates of 3% to 6%, range 0% to
11.5%, while studies with a longer period between treatment and follow-up portray an
even grimmer picture, with mortality rates between 0% and 17.5% (Fichter, Quadflieg, &
Hedlund, 2006). Several studies have attempted to establish outcome predictors.
Following regression analysis, 11 variables predictive of outcome appear to be similar
across studies: duration of the eating disorder, age of onset, family of origin, age at onset
of menstruation, sexual problems, psychiatric comorbidity, perfectionism, impulsivity,
self-evaluation, extroversion, and low body weight (Fairburn, Cooper, Doll, & Welch,
1999; Keel & Mitchell, 1997; Lindberg & Hjern, 2003; Quadflieg & Fichter, 2003;
Steinhausen, 2002). These predictive variables may present in a wide variety of
constellations. Other problems with the development of effective and empirically based
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treatments for anorexia include the small sample sizes of the studies and their contrasting
results.
A recent investigation by Fichter, Quadflieg, and Hedlund (2006) followed 103
individuals for 12 years who were admitted for the treatment of anorexia. Follow-ups
were conducted at 2, 6, and 12 years posttreatment. The investigation of Fichter et al.
(2006) provided important results due to the long-term follow-up and large sample size.
The results of this study were illuminating and shed light on a series of factors that ought
to be incorporated into the successful treatment of anorexia. These variables, shown in
Table 1, exemplify factors consistent across a large sample size.
The greatest predictor of poor outcome for anorexia is sexual problems. This
variable includes body contact, sexual arousal, and related feelings. Two
conceptualizations are obvious when discussing the role of this variable in the
maintenance of anorexia. Sexual problems may relate to factors involving maturation,
self-identity, self-esteem, as well as societal conceptualizations of the sexualized female
form. This variable highlights the possible interaction of sexual abuse and lingering
intimacy concerns in the maintenance of anorexia. Participants in this study who had
experienced sexual abuse before the age of 11 had significantly higher sexual problems
and poorer outcome rates. This demonstrates the importance of treating sexual problems
in individuals struggling with anorexia. The second primary predictor of poor outcome of
treatment in individuals with anorexia was impulsivity, also a commonly accepted
predictor of bulimia. The last two significantly predictive variables were duration of
inpatient stay and duration of eating disorder. The more time an individual spent in an
inpatient setting, the worse his or her prognosis became. Similarly, the longer an
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Table 1
Final Predictive Model of Poor Eating Disorder Outcome 12 Years After Index
Treatment in Anorexia Nervosa (Fichter et al., 2006)
R2 = 0.45 predictor

Wald statistics Odds ratio 95% CI

1 High intensity of sexual problems

6.9**

5.08

1.51–17.09

2 Impulsivity

4.9*

3.71

1.16–11.87

3 Long duration of index inpatient treatment 4.2*

1.52

1.02–2.28

4 Long duration of eating disorder

1.27

1.09–1.47

9.7**

Note. 95% CI = 95% confidence interval.
* p < .05.
**p < .01.

individual suffered from anorexia, the greater his or her chances were of achieving a poor
outcome.
While the predictors found in the investigation of Fichter et al. (2006) are
important, Fichter et al. also reported interesting results regarding individuals in
remission from anorexia. The typically accepted definition for recovery from anorexia,
weight being within 15% of ideal body weight (le Grange & Rock, 2005), may not be an
adequate predictor of eating disorder remission or recovery. Despite no longer meeting
the diagnostic criteria for anorexia, these individuals still maintain significantly different
characteristics from the normal population. For example, recovered individuals
maintained significantly higher levels of eating-disordered behaviors and general
psychopathology. Recovered anorexics also maintained certain pathological attitudes in
regard to the thin ideal and body image. Interestingly enough, there was no difference
between non-eating disordered women and the recovered individuals in regard to eating-
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disordered characteristics related to binge eating, atypical compensatory behaviors, or
restrictive eating patterns. These results further highlight the difficulty in treating body
image disturbance despite an alleviation of food-related eating disordered behaviors. Le
Grange and Lock (2005) completed a review of all literature reporting on therapeutic
treatments and/or efficacy for anorexia. They identified eight uncontrolled and five
controlled studies examining the treatment of adolescents with anorexia, and seven
controlled investigations on the treatment of adults with anorexia. There is clearly a
dearth of literature and research examining the treatment of this life-threatening disorder.
In 1975, Minuchin and associates completed what is now considered a seminal
work for the treatment of adolescents with anorexia. In an uncontrolled investigation at
the Child Guidance Clinic in Philadelphia, PA, they treated 53 adolescent patients with
family therapy and wrote an article discussing their results (Minuchin, Baker, Rosman,
Liebman, Milman, & Todd, 1975; Minuchin, Rosman, & Baker, 1978). The individuals
in this study were largely comprised of adolescents (only 3 were greater than 18 years of
age) diagnosed with anorexia for 8 months or less. Minuchin and associates reported very
high success rates. Eighty-six percent of the patients were reported recovered at the time
of follow-up. While the results appear very promising, it is important to remember that
duration of illness is most likely a primary predictor of outcome and that the short
duration of the illness might have positively impacted recovery rates. Regardless, the
work of Minuchin and his associates was impactful for two reasons: (a) the number of
recovered individuals was large, and (b) the theoretical underpinnings of their approach
could be replicated.
Minuchin and associates (1975) conceptualized a “psychosomatic family” that
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was at the core of an individual’s struggle with anorexia. The “psychosomatic family”
consisted of a particular family process in which family members were enmeshed, rigid,
and highly avoidant of conflict. This family system sets the stage for an individual, when
coupled with the developmental demands of adolescence, to develop anorexia as a way of
navigating the system. Minuchin and associates (1975) cautioned against seeing their
theory as an etiologic concept of how anorexia develops, urging readers instead to
consider the eating disorder within this framework as a constantly shifting and evolving
part of the family process. Therefore, the ultimate goal of the Minuchin treatment was to
alter the family’s interactive engagement.
It wasn’t until 1987 that a group of researchers at the Maudsley Hospital in
London attempted a systematic investigation of the Minuchin methodology. Russell,
Szmukler, Dare, and Eisler (1987) examined the effectiveness of individual outpatient
therapy as compared to family therapy in adolescents with anorexia. While Russell and
associates largely recreated the environment of Minuchin’s treatment, they added in
several new key variables. For example, they engaged the parents in the refeeding
process of the adolescents and maintained parental involvement in this matter until
weight was restored. They also did not begin to address individual or family concerns
until after weight restoration was achieved. Russell et al. (1987) compared family therapy
to a systematized supportive individual therapy conceptualized as “treatment as usual.”
Results of these studies showed promise for the method conceptualized by Minuchin and
associates (1975). At the 5-year follow-up, only 36% of patients who received individual
therapy reported a favorable outcome, whereas 90% who received family therapy had a
positive outcome.
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More recently, other investigators have compared different forms of family
therapy for the treatment of adolescent anorexia. These studies found that regardless of
the type of family therapy (conjoint family therapy vs. separated family therapy),
individuals receiving family therapy still had significantly better outcome results than did
those just receiving individual therapy (Eisler, Dare, Hodes, Russell, Dodge, & Le
Grange, 2000; Morgan & Hayward, 1988). Eisler et al. (2000) also found results for
families and individuals who participated in conjoint family therapy. At 5-year follow-up,
75% of patients who received some form of family therapy had a positive outcome, as
compared to 15% who had good outcomes with individual therapy. Another study
investigated outcomes with behavioral systems family therapy as compared to egooriented individual therapy (Robin, Siegel, Moye, Gilroy, Dennis, & Sikand, 1999).
Robin and associates found that individuals who received family therapy were
significantly more likely to return to normal weight and to have regained their menses.
Interestingly, the two groups showed no difference in regard to changes in depression,
eating attitudes, and eating-related family conflict. These results emphasize the potential
role of the family in the physical aspect of recovery but not in the more cognitively
oriented aspects of recovery. This is an essential differentiation, as almost all studies, to
date, have defined an individual as recovered from anorexia if he or she has returned to
normal weight.
In comparison to studies examining adolescents with anorexia, studies examining
interventions for adult individuals with anorexia are just as difficult to find. Before le
Grange and Lock’s review (2005) of the treatment of anorexia, there had only been seven
studies examining outpatient therapy outcomes of individuals with anorexia. These
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studies examined a variety of therapies such as individual therapy, cognitive behavioral
therapy, individual therapy combined with family therapy, group therapy, dietary
counseling, and nutritional advice. Similar to the studies on individuals with bulimia and
adolescents with anorexia, all outcome results were based on posttreatment reported
results via either a self-report questionnaire or a clinical interview.
In 1987, the first controlled trial investigating outpatient treatment results on
adults with anorexia was published. Thirty-six patients were randomly assigned to
receive either individual or family therapy following discharge from the hospital (Russell,
Smuzkler, Dare, & Eisler, 1987). Although those who received individual therapy
showed an initial improvement over those receiving family therapy at the 5-year
mark, there was no significant difference between the two groups. Another study found
similar results when examining two different types of individual therapy, focal therapy
and cognitive analytic therapy, when compared to family therapy (Dare, Eisler, Russell,
Treasure, & Dodge, 2001). No single form of therapy proved more efficacious than the
others at the time of treatment termination. Numerous other studies investigating and
comparing a variety of treatment modalities for anorexia have found similar results, with
no significant difference between the groups at time of termination (Channon, De Silva,
Hemsley, & Perkins, 1989; Crisp, Norton, Gowers, Halek, Bowyer et al., 1991; Treasure,
Todd, Brolly, Tilley, Nehmed, et al., 1995).
Only two studies examining controlled treatment effects on adults with anorexia
had significant results. One study compared nutritional counseling to outpatient CBT in
33 women posthospitalization (Pike, Walsh, Vitousek, Wilson, & Bauer, 2003). This
investigation was more empirically sound than those previously noted because it utilized
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manualized treatment interventions. It is also important to note that this investigation was
significantly more intense than the previous studies and consisted of 50 treatment
sessions over a course of 12 months. Results of this study indicated a significantly lower
nonresponse rate for individuals in the CBT group. Furthermore, when the researchers
applied Fairburn and Cooper’s (1993) criteria of a good outcome –i.e., no binge eating or
purging behaviors, weight restored, and < 1 standard deviation (SD) from the norm on the
Eating Disorder Examination (EDE; Fairburn & Cooper, 1993), none of the individuals in
the nutritional counseling group were shown to have a good outcome, while 17% of those
in the CBT group did. While the results of this study are mildly discouraging, they
portray the reality of current treatment outcomes for women struggling with anorexia.
Another interesting study examined two of the specialized therapies purported to
be the most efficacious for eating disorder treatment. McIntosh et al. (2005) examined the
effectiveness of CBT and IPT compared to a treatment-as-usual group. Interestingly, after
20 sessions for 20 weeks, the control treatment group had treatment outcomes that were
superior to those of either CBT or IPT. The results of this study, as well as the previously
discussed studies, indicate the difficulty in creating and implementing an effective
treatment strategy for anorexia. These studies reported results of “good” and
“intermediate” outcomes as anywhere from 29% to 63%, with the majority of individuals
falling into the 60% range. It is also extremely important to remember that in all but one
study, there were no follow-up data. The previously discussed long-range follow-up data
of 12 years posttreatment paint a much grimmer picture, with mortality rates of up to
17.5% and only 52.4% of participants obtaining recovery (Fichter, Quadflieg, &
Hedlund, 2006).
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In an unprecedented investigation, Kordy and associates (2002) examined 422
bulimic and 233 anorexic patients over the course of 2.5 years. Utilizing the Longitudinal
Follow-up Evaluation, they attempted to establish operational definitions for partial and
full remission, relapse, and recovery for individuals with anorexia and bulimia (Frank et
al., 1991). Given the previously discussed difficulties with defining outcome in this
population, their task was not an easy one.
Utilizing the operational definitions provided in Table 2, the treatment progress of
a total of 655 patients was assessed using the Kaplan-Meier Survival Analysis to
determine the chances for remission or recovery as well as those for relapse or
recurrence. Partial remission was the most commonly observed clinical phenomenon.
Twenty percent of the anorexic patients and 30% of the bulimic patients had progressed
to this stage of treatment at the time of entering the posttreatment stage. These
proportions did increase through the posttreatment stage to 55% for anorexics and 60%
for bulimics. Full remission or recovery was a significantly rarer occurrence (Figure 4),
with only 7% of anorexics and 18% of bulimics achieving full remission. Only 6% of
anorexics and 16% of bulimics were considered recovered (Figure 5).
Kordy and associates' (2002) research pinpointed important findings about the
stability of remission and recovery in these disorders. Full remission and recovery was
more stable than partial remission. Out of the 22 anorexic patients who obtained full
remission or recovery during the 2.5 years of observation, only 2 relapsed (1 in Month 6
and 1 in Month 21). Partial remission was much less stable, with 35% of the anorexic
patients obtaining partial remission relapsing. During the first 7 months of achieving
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Table 2
Kordy and Associates (2002) Operational Definitions of Possible Eating Disorder
Treatment Outcomes

Symptom

Concept
Full Remission
(3 months)

Partial Remission
(1 month)

Anorexia:
Restricting Type
Underweight
BMI > 17.5
2
(kg/m )
Fear to gain weight -Weight reduction by Vom.a & Laxb. = 0
(#/wk)
Binges (#/wk)
0
Anorexia: Binge
Purge Type
Underweight
BMI>17.5
2
(kg/m )
Fear to gain weight -Binges (#/wk)
≤1
Weight reduction by Vom. & Lax. = 0
(#/wk)
Bulimia
Binge/Purge (#/wk) ≤ 1
Preoccupation with -figure
Weight reduction by Vom. & Lax. ≤ 0
(#/wk)

Recovery
(12 months)

BMI > 19

BMI > 19

No extremes
Vom. & Lax. = 0

No extremes
Vom. & Lax. = 0

0

0

BMI>19

BMI>19

No extremes
0
Vom. & Lax. = 0

No extremes
0
Vom. & Lax. = 0

0
No extremes

0
No extremes

Vom. & Lax. = 0

Vom. & Lax. = 0

Relapse: change from partial or full remission to full syndrome according to DSM-IV
Recurrence: change from recovery to full syndrome according to DSM-IV
a
b

Weight reduction by vomiting
Weight reduction by laxative abuse
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Figure 4. Graphical Representation of Partial Remission in Eating
Disorder Treatment (Kordy et al., 2002).

Figure 5. Graphical Representation of Full Remission in Eating
Disorder Treatment (Kordy et al., 2002).
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partial remission, the risk of relapse for these patients was 5 times higher, with risk rates
steadily decreasing after this period. Bulimic participants showed no significant
differences between relapse risk for partial/full remission and recovery. Interestingly,
patients in full remission or recovery were significantly more vulnerable to relapse during
Months 4 through 6 of their remission-recovery period. After the 6-month mark, risk of
relapse decreased dramatically. Of those who obtained partial remission at the
posttreatment stage, only 40% maintained this state, with 60% relapsing. Up to the 6th
month, the risk for relapse for partially remitted bulimics displayed similar relapse risk
percentages as for the fully remitted/recovered patients.
Kordy’s (2002) work was the first attempt to operationally define the treatment
trajectory for this patient population. The results indicate the difficulty in treating these
patients and the necessity for long-term care, significantly highlighting the most
vulnerable stages of the treatment process. Clearly, treatment of these disorders is
difficult and may at times seem impossible. With such a widely varied etiology, brain
abnormalities lasting past recovery, and such a large variety of risk factors involved, how
can a single treatment be successfully applied to all individuals struggling with this
disorder? Each individual presenting with an eating disorder may, in actuality, be unique
in etiology and symptom presentation of the eating disorder. The unfortunate outcome of
this is that no treatment center or clinician will be able to apply a manualized treatment to
all clients and expect strong outcome results.
Dishearteningly, too many patients and clients slip through the cracks of eatingdisorder treatment due to the lack of knowledge and/or research regarding the efficacious
treatment of their illness. One way to shed light on the highly varied presentations of

60

these disorders, and to prevent patients and clients from being treated by a therapeutic
modality that does not address their concerns, is to monitor treatment progress throughout
the treatment program. This review has examined numerous longitudinal studies for the
treatment of eating disorders, and yet no single review was anything but either preand/or post-treatment. A continued mechanism of evaluation of treatment progress will
increase the treatment provider’s ability to change treatment modalities should treatment
progress not be ideal.

Measuring Treatment Outcomes
In 1984, the World Health Organization implemented project “Health 2000,”
committing member states to the development of measures to assess and assure quality
health care services (World Health Organization, 2001). This initiative began a serious
push toward the medical field’s focus on outcome measurements. As health management
systems grew increasingly powerful and cost-effectiveness plans began to take priority,
measures of health care quality, effectiveness, and treatment outcomes began to have
serious social and political implications. Similarly, as consumers began to demand more
transparency from the medical field, expectations of health care providers to provide
empirically based results of reported successes also continued to rise. Today, while the
numbers of outcome studies are still small, they are growing, driven by organizations as
large as the National Institute of Mental Health and as small as private clinics seeking
cost containment through ultimate efficiency.
Part of the increased focus on outcome measurements for psychotherapy stems
from the realization that patient deterioration in psychotherapy is well documented,
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although very little is known about the prevalence, rate, or magnitude of the deterioration.
Some researchers posit that rates of deterioration are as low as 5% but may be as high as
15% (Lambert & Bergin, 1994). The suggested rates of deterioration are not specific to
any patient population, theoretical orientation, or treatment modality, and are even
consistent in group and family therapies (Mohr, 1995; Shapiro & Shapiro, 1982; Smith,
Glass, & Miller, 1980). Rates of deterioration have even been noted in groups that
receive no treatment (Lambert, DeJulio, & Stein, 1978). The possibility of patient
deterioration is a threat to all clinicians and needs to be more fully researched in order to
provide effective client care.

Outcome Research Modalities
The majority of treatment outcome research is designed as efficacy research.
These investigations seek to minimize variance between external variables and maximize
the control of internal variables. Through stringent methodologies, treatment effects are
thus isolated and measurable. While efficacy research is accepted as the “Gold Standard”
in this research arena (Kendall, 1998; Wells, 1999), results are typically not
generalizable, given the strict controls implemented on treatment in the research
environment. Due to lack of generalizability noted in efficacy research, clinicians are
starting to turn to the use of effectiveness research in order to measure and assess the
success of various treatment modalities. Effectiveness research relies upon routine
clinical practice to assess the real-world clinical success of different treatments. The
focus here is on ecological validity rather than internal validity, such as that sought in
efficacy treatment. This shift in focus allows clinicians and researchers to draw
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generalizable conclusions about the success of different treatment modalities. In
summary, efficacy research attempts to measure the potential success of a treatment in
ideal treatment conditions. Effectiveness research examines how well a treatment works
in a real-world setting (Howard, Moras, Brill, Martinovich, & Lutz, 1996).
While efficacy research and effectiveness research elucidate important aspects of
treatment efficacy, they both focus solely on group response to treatment (Howard et al.,
1996), neglecting to maximize the effect of treatment being studied. In 2001, Lambert
proposed the use of treatment outcome management procedures in order to improve
treatment effects. Drawing upon the idea of patient-focused research (Howard et al.,
1996), Lambert suggested that treatment response should be measured continually, with
feedback provided to clinicians in order to enable clinicians to track treatment and make
treatment plan modifications as necessary.
Patient-focused research seeks to answer the most pressing question facing
treatment providers: Is this patient responding to this treatment? To answer this question,
Howard and associates (1986; 1993) utilized dose-response and phase models of
treatment effectiveness to develop a method of patient profiling designed to provide
continuous feedback on individual patient treatment responses. Data pertinent to
treatment success are continuously collected and modeled on a graph. This data are then
compared to an expected progress pattern developed for each patient based on clinical
characteristics. Patient-focused research aids in the early identification of patients who
are not responding to treatment at expected levels, allowing for alterations in the
treatment plan in an effort to change the treatment outcome. Lambert, Hansen, and Finch
(2001) stated three defining qualities for patient-focused research: (a) evaluates
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individual patient progress over the course of treatment, (b) provides regular feedback to
treatment providers, and (c) “attempts to answer the question, Is this particular treatment
working for this patient?” (p. 159).
Efficacy, effectiveness, and patient-focused research are all valuable contributors
to the wealth of research available concerning treatment outcomes. While the three are
complementary procedures, there are distinct and important differences in their processes.
Although efficacy and effectiveness research are widely recognized as the foundation of
evidence-based practice, they are characterized by a top-down approach to patient care.
Because of their methodology, they do not allow for the consideration of patients’
individual differences. Patient-focused care, on the other hand, presents a bottom-up
approach to care that is driven by patient-specific information and geared toward
enhancing patient outcomes.

Patient-Focused Research Models
To date, there are two primary patient-focused research models for measuring, or
modeling, therapeutic outcome results: the Brigham Young University Model and the
Stuttgart-Heidelberg Quality Assurance Model (Percevic, Lambert, & Kordy, 2004). The
researchers at Brigham Young University have largely focused on predicting treatment
failure. Their research has developed operational definitions for treatment success and
treatment failure (Lambert & Finch, 1999; Wells, Burlingame, & Morrell, 2002). A main
theoretical underpinning of the Brigham Young University model is that early treatment
response predicts outcome and treatment nonresponse is indicative of treatment failure.
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Therefore, through appropriate outcome measurements, clinicians can identify early
nonresponders and change treatment accordingly.
Utilizing a system developed by Lambert and associates to track patient progress
session to session, clinicians are able to receive a large amount of data regarding their
patients’ potential clinical outcomes. Lambert and colleagues engaged in a series of
investigations analyzing the impact of feedback to clinicians on overall patient outcomes
(Lambert, Whipple, Smart, Vermeersch, Nielsen, et al., 2001; Lambert, Whipple,
Vermeersch, Smart, Hawksin, et al., 2002). These investigations found that feedback
significantly improved the outcome of patients who were deteriorating in treatment or at
risk for dropping out. Lambert and associates (2003) demonstrated that feedback on
client outcomes, when provided regularly to clinicians, provides benefits that are not only
substantial, but also replicable. One controlled investigation reduced patient deterioration
rates to 13% in the clinician feedback group as compared to 21% in the treatment-asusual group. Improvement and recovery rates were similarly affected, improving to 35%
in the feedback group from a baseline of 21%.
The Stuttgart-Heidelberg quality assurance model was developed in Germany at
the Center of Psychotherapy and Research, Stuttgart. The model, similar to the Brigham
Young model, began using continuous treatment outcome monitoring to develop a more
thorough understanding of symptom course (Kordy, Hannöver, & Richard, 2001; Kordy
& Lutz, 1995). The researchers found the symptom courses of their patients graphed as
linear trends moving toward improvement. Each patient presented with independent
change rates and significant residual fluctuation. Spitzer (2001) defined similar courses of
treatment as “random walks.” The Stuttgart group adopted the random walk model as the
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theoretical basis for the Stuttgart-Heidelberg quality assurance model.
The primary benefit of outcome monitoring utilizing the random walk model is
that it allows healthcare providers to integrate an adaptive allocation of therapeutic
resources and a cost efficiency component to the treatment of their clientele. Through an
assessment of current outcome and intended outcome, clinicians are able to provide
appropriate treatment, i.e., they know when to terminate therapy for a client who is no
longer suffering and know when to extend treatment to those who are not responding to
treatment as expected. The Stuttgart model differs from the Brigham Young University
model in that it does not rely upon prior data to assess whether the patient is responding
as expected. Early nonresponse to treatment is not an indication of the patient’s overall
outcome. Instead, the model focuses on the client in the “here and now,” assessing the
presence of dysfunction throughout the course of therapy. The presence of dysfunction at
any given point is indicative of further therapeutic intervention being necessary.
Research supports the adaptation of therapeutic treatment time to match client
distress. Percevic (2003) reported that utilizing the random walk model with continuous
outcome monitoring, 85% of the experimental group achieved significant clinical
improvement, as compared to 65% of the control group. In this same study, Percevic also
examined therapy duration and found that with the appropriate allocation of therapeutic
resources and monitoring, treatment duration could drop to as few as 19 sessions (down
from 52) with the same levels of client improvement.
Although relying on a different theoretical foundation, both feedback models
clearly result in benefits to both clients and clinicians. Percevic and associates (2004)
hypothesized that much of the benefit noted by clients is due to an “attention effect.”
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Simply stated, therapists paid more attention to client progress when provided with
continuous feedback about their client. Many theorists also apply the law of diminishing
returns to therapy, believing that the more therapy one receives, the less effective it
becomes over time, and that therapy may, if utilized for too long, actually become
detrimental to the client (Howard, Kopta, Krause, & Orlinsky, 1986). Therefore, the
appropriate allocation of therapeutic resources is similarly key in effective client care.

Conclusion
With a reported treatment deterioration rate of 5% to 15% expected across all
patient populations (Lambert & Bergin, 1984) combined with the notoriously difficulty in
treating eating disorders, only 13% of anorexics and 34% of bulimics achieve full
remission or recovery by the end of the posttreatment stage (Kordy et al., 2002). Accurate
outcome treatment measures are crucial. The varied etiology and symptom presentation
of these disorders make treatment extremely difficult. Patients respond in a variety of
manners to different treatment paradigms as well as at different rates (Kordy, Haug, &
Percevic, 2006), further enhancing the difficulty in providing effective patient care.
Given the longstanding nature of an eating disorder, it is not unusual for a patient
to progress through a variety of treatment stages as his or her treatment progresses. As
patients work toward recovery, their treatment must be appropriately tailored to meet
their needs. Again, one is reminded of the law of diminishing returns in therapy (Howard
et al., 1986) as well as the importance of appropriate allocation of therapeutic resources.
One of the most difficult aspects of treatment to assess is when it is the appropriate time
to transition from one therapeutic modality to the next, be it higher or lower level care
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(Kordy et al., 2006). A number of researchers have relied upon a theoretical backing
similar to the Brigham Young model to assess patient outcomes and appropriate
treatment transition points. For example, Agras and associates (2000) reported that
patients who responded early to treatment had better outcomes than those who responded
to treatment later. Outcome monitoring systems have been implemented with this
ideology in mind, with an eye toward assessing when patients are not meeting treatment
goals. This allows clinicians to plan interventions that inhibit patient deterioration or
dropout.
Recently, Percevic and associates (2006) reported that symptom change across
therapy was negatively correlated with immediate treatment responders making strong
gains at first but then decreasing gains as therapy continued. Inversely, slow or nonresponders at the beginning of therapy were seen as making large treatment gains later in
therapy. This has important implications for the treatment of eating disorders. Often,
patients considered to be non-responders are moved to a higher level of care and quick
responders are held to the standard course of therapy designed by the treatment program.
Both of these actions have important implications for the successful allocation of
therapeutic resources and the overall treatment of patients.
Current treatment for an eating disorder is designed to meet the standard
demanded either by insurance companies or by treatment providers. As providers become
more accustomed to a standardized treatment course, it is often easier to simply “go
through the motions” with each new patient rather than assess patients for their individual
treatment needs. If, however, as research has shown (Agras et al., 2001), patients do
respond to treatment at a variety of speeds and levels, then treatment does need to be
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tailored to match each patient, allowing for the most effective use of therapeutic
resources and the most beneficial client care. Kordy and associates (2006) called this type
of treatment Individually Tailored Service Allocation.
Individually tailored service allocation implies that treatment outcomes cannot be
known from the beginning of intake; instead, treatment must be consistently monitored
and feedback supplied to the treatment team. Feedback monitoring reports allow the
treatment team to regularly assess the patient’s treatment progress and reassess expected
outcomes as treatment continues. This feedback allows for the tailoring of individual
treatment plans to consistently meet the unique and varied needs of each patient (Kordy
et al., 2006). This approach allows for an integration of all of the successful therapy
approaches for eating disorders and consistent monitoring and tailoring of these
approaches to help patients obtain optimal treatment. Furthermore, should a patient be an
early responder, patient monitoring will disrupt the cycle of the rule of diminishing
returns by ensuring that a change in service provision will match patient needs.
The purpose of this investigation is to examine the effect of Individually Tailored
Service Allocation on therapeutic outcomes in an eating disorder program. This study
will use the Outcome Questionnaire–45 and the Outcome Questionnaire Analyst to assess
patient progress and provide progress reports to therapists. In consideration of the
literature reviewed, several questions present themselves: (a) Does treatment in a partial
hospital program for eating disorders significantly affect global psychological
dysfunction over time? (b) Does initial disease severity affect change in global
psychological dysfunction over time? (c) Does provision of feedback about treatment
response to therapists significantly affect global psychological dysfunction over time? (d)
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Does feedback moderate the relationship between nonresponse to treatment and treatment
outcome over time? (e) Does therapist receipt of treatment response feedback account for
unique variance in differences in length of treatment? (f) Does feedback account for
variations in the point at which global psychological dysfunction reaches its maximum ?
(g) Does therapist receipt of treatment response feedback account for unique variance in
the rate of change from the point of maximum global psychological dysfunction to
discharge from treatment?

Aims, Hypotheses, and Exploratory Questions
Aim 1
To examine change in global psychological dysfunction over the course of
treatment in a partial hospital eating disorder program.
Hypothesis 1a. A significant decrease in average global psychological
dysfunction will be observed over the course of treatment for patients in a partial hospital
eating disorder program.
Hypothesis 1b. Significant interindividual differences in intraindividual change
will be observed—that is, the pattern of change of individual patients will vary relative to
the sample-level trajectory of change.
Aim 2
To examine the effect of the initial level of global psychological maladjustment
on change in global psychological dysfunction over the course of treatment in a partial
hospital eating disorder program.
Hypothesis 2. Initial disease severity will account for a significant amount of
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variance in the hypothesized decrease in average global psychological dysfunction over
the course of treatment. Decrease in global psychological dysfunction will be greater for
patients with lower initial levels of disease severity.
Exploratory question 2. To what extent do low self-esteem, interpersonal
problems, affective problems, perfectionism, and facets of disease severity impact change
in global psychological dysfunction over the course of treatment? Of the facets shown to
be related to change over the course of treatment, is the nature of the relationship such
that more severe maladjustment impacts the decrease in global psychological
dysfunction?

Aim 3
To examine the effect of enabling greater individualized tailoring of service
allocation through provision of feedback about response to treatment on decrease in
global psychological dysfunction over time in a partial hospital eating disorder program.
Hypothesis 3a. Differential treatment outcomes in the form of between-individual
rates of change will be shown for patients whose therapists receive feedback such that
patients whose therapists receive feedback will demonstrate a significantly greater
decrease in patient global psychological dysfunction as compared to those to whose
therapists’ feedback is not provided.
Hypothesis 3b. Consistent with the notion of Individually Tailored Service
Allocation (Kordy et al., 2006) in which patient information at intake is not considered
wholly predictive of treatment outcome, therapist receipt of treatment response feedback
will account for unique variance in between-individual rates of change.
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Hypothesis 3c. Therapist receipt of feedback will moderate the relationship
between nonresponse to treatment and treatment outcome over time such that
nonrespondent patients whose therapists receive feedback will show a significantly
greater decrease in global psychological dysfunction as compared to those to whose
therapists’ feedback is not provided.

Aim 4
To examine the effect of enabling greater individualized tailoring of service
allocation through the provision of feedback about response to treatment on length of
treatment in a partial hospital eating disorder program.
Hypothesis 4. Therapist receipt of treatment response feedback will account for
significant unique variance in length of treatment in the partial hospital program (PHP)
over and above that accounted for by disease severity at time of intake, such that total
treatment length will be shorter for patients whose therapists receive feedback as
compared to those to whose therapists’ feedback is not provided.
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Methods and Analyses
The following section provides a thorough review of the methods and analyses
utilized for this research investigation. First the demographics of the participating patients
and clinicians will be presented, followed by an examination of the measures used.
Finally, a comprehensive introduction to Hierarchical Linear Modeling concludes this
chapter.
Participants
A total of 58 patients receiving treatment at the Valenta Inc., Eating Disorders
Program (Valenta) participated in this study. Patients with fewer than six Outcome
Questionnaire (OQ) measurement occasions (i.e., a minimum of 3 weeks of treatment at
Valenta) were removed from the data set. Final data analysis included 51 adult women
with a primary diagnosis of either anorexia nervosa or bulimia nervosa (Table 3). Patients
ranged in age from 18 to 49 (M =24.14, SD = 7.03). Upon intake, patients were
administered a battery of assessments including the Outcome Questionnaire-45 (OQ-45)
and Eating Disorders Inventory 3 (EDI-3). Demographic data were collected as part of
the routine intake assessment interview. Patients were randomly assigned to one of the
two treatment conditions: experimental (feedback) or control (no feedback). During the
course of the study, the Outcome Questionnaire-45.2 was used to assess patient global
psychological dysfunction twice a week. All patients completed the OQ-45 as part of
their check-in procedures every Monday and Thursday morning throughout their course
of treatment at Valenta. The OQ-45 was administered using a Dell Axim X5 Pocket PC
with the Outcome Questionnaire Analyst (OQ-A) software.
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Table 3
Characteristics of Patients
Variables
Gender
Female
Diagnosis
Anorexia Nervosa
Bulimia Nervosa
Age eating-disordered behaviors began
Duration of eating disorder
Number of outcome questionnaires
administered
Eating Disorders Inventory– 3
Composite Scales
Global Psychological Maladjustment
Ineffectiveness Composite
Interpersonal Problems Composite
Affective Problems Composite
Overcontrol Composite

N

%

51

100%

24
27

47.1%
52.9%

x

SD

Range

14.9
9.5
25.8

4.7
6.6
11.4

8-33
1.3-27
6-53

48.2
48.2
51.0
48.1
46.5

6.9
8.2
7.3
8.1
8.8

33-61
31-64
34-65
32-68
29-63

Participating Clinicians
Three therapists from Valenta participated in this study. Two were licensed
marriage and family therapists, and the third therapist was a social worker. All therapists
worked under the guidance of the Valenta Medical Director as well as with a nutritionist.
The purpose of the study was explained to the participating therapists, and they were
made aware that they would receive feedback on only half of their patient load.
Assignment of patients to therapists was performed using routine intake procedures. It
was assumed that the numbers of participants in the experimental and control conditions
seen by each therapist were equal, and therefore no steps were necessary to alleviate
potential therapist assignment effects. As indicated in Table 4, Therapist 3 was randomly
assigned roughly 25% more patients who were in the feedback group than either
Therapist 1 or Therapist 2. A multiple regression analysis was conducted to evaluate the
prediction of therapist assignment and feedback group assignment on OQ change score.
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Table 4

Participant Assignment to Therapist and Feedback Groups
Feedback group
No feedback

Measure
Therapist

Count

Feedback

Row N %

Count

Total

Row N %

Count

Row N %

1*

9

52.9%

8

47.1%

17

100.0%

2*

8

53.3%

7

46.7%

15

100.0%

4

21.1%

15

78.9%

19

100.0%

3**
* Marriage and Family Therapist
** Social Worker

R2 = .02, F(2, 48) = .49, p = .615. Neither therapist assignment nor feedback group
assignment significantly predicted OQ change scores. A one-way analysis of variance
was conducted to evaluate the relationship between therapist assignment and the OQ
change score, assessing for overall change in global psychological dysfunction at
treatment end. The analysis of variance (ANOVA) was not significant, F(1, 49) = .001, p
= .98, indicating that therapist assignment did not result in a significant change in global
psychological dysfunction. Based on these results, it has been assumed that the unequal
distribution of the feedback and no feedback group patients amongst the therapists will
have no significant impact on subsequent analyses.

Measures
The Outcome Questionnaire-45 (OQ-45)
The OQ-45.2 is part of a quality management system developed by Lambert and
colleagues (see Lambert, Hansen, et al., 2001) in 1996. It was developed in part from the
work of Howard et al. (1986) examining the dose-effect relationship in therapy. Lambert
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and Hansen et al. (2001) use the OQ-45 as an operationalization of patient treatment
outcomes. A brief, self-report measure, the OQ-45 is used to track both the magnitude
and rate of change throughout the course of treatment (Brown, Burlingame, Lambert,
Jones, & Vaccaro, 2001). The questionnaire is composed of 45 questions, each based on
a 5-point Likert scale (0 = never; 1 = rarely; 2 = sometimes, 3 = frequently; 4 = almost
always) and results in scores ranging from 0 to 180. Patient progress, as assessed by the
OQ-45, is based on monitoring three aspects pertinent to therapeutic outcomes: (a)
subjective discomfort, (b) interpersonal relationships, and (c) social role performance.
These three measurements result in three subscale scores. The OQ Total Score provides a
global assessment of patient functioning (Lambert, Whipple, et al., 2001).
Lambert and associates (1996; 2004) found the OQ to have adequate internal
consistency (r = .93). The OQ also has a satisfactory test-retest value at the 3-week mark
(r = .85; Lambert, Burlingame, et al., 1996; Lambert et al., 2004). The OQ also has
normative data based on data collected throughout the United States (Lambert,
Burlingame, et al., 1996; Lambert, Hansen, et al., 1996; Umphress, Lambert, Smart,
Barlow, & Clouse, 1997). The OQ-45 is indicated to be reliable, valid, and sensitive to
change (Lambert et al., 1998). To facilitate the interpretation of scores, criteria for
reliable and clinically significant change have been developed based on the criteria
outlined by Jacobson, Follette, and Revenstorf (1984). The cutoff point for
differentiating between a normal and a dysfunctional state has been set at a score of 64,
and the reliable change index has been calculated to be 14 points. Based on these criteria,
patient outcome can be determined by comparing OQ-45 scores to previous feedback
reports, as well as through examining projected outcome curves.
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Feedback on Progress
The OQ system enables the generation of feedback reports that can inform
therapists of patient progress in treatment. Feedback reports take the form of a progress
graph in which patient status is communicated using a system of color-coded feedback
messages (see Figure 6). Decision rules for determination of feedback message are based
on baseline OQ score, number of treatment sessions completed, and change from most
recent OQ score as compared with the baseline score.
In consideration of therapeutic progress, as indicated by decision rules, one of four
feedback messages may be given (Lambert et al., 2001):
White feedback: “The client is functioning in the normal range. Consider
termination.”
Green feedback: “The rate of change the client is making is in the adequate range.
No change in the treatment plan is recommended.”
Yellow feedback: “The rate of change the client is making is less than adequate.
Recommendations: Consider altering the treatment plan by intensifying treatment,
shifting intervention strategies, and monitoring progress especially carefully. This client
may end up with no significant benefit from therapy.”
Red feedback: “The client is not making the expected level of progress. Chances
are she may drop out of treatment prematurely or have a negative treatment outcome.
Steps should be taken to carefully review this case and decide upon a new course of
action such as referral for medication or intensification of treatment. The treatment plan
should be reconsidered.”
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Figure 6. Sample OQ-A Feedback Report Provided to Therapists.

As a result of the ease with which the OQ can be scored and the elegant simplicity
of the system of decision, OQ scores can be graphed and appropriate feedback message
determined quickly after administration, enabling the provision of prompt feedback on
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patient progress to therapists. Through the use of tools for administration and scoring
such as Outcome Questionnaire Analyst (OQ-A) software, it is possible to generate nearinstantaneous feedback.

Eating Disorder Inventory-3 (EDI-3)
The Eating Disorder Inventory – 3 (EDI-3; Garner, 2004) was created in 1983 to
serve as a self-reported measure of attitudes and behaviors associated with bulimia
nervosa and anorexia nervosa (Garner et al., 1983). In 1992, an update of the Eating
Disorder Inventory (EDI) was released, the Eating Disorder Inventory – 2 (EDI – 2),
which involved the addition of three provisional scales; the original eight scales remained
intact. In 2004, Garner released the EDI – 3, which is an extension of the EDI and EDI –
2. The EDI – 3 includes scales and composites of eating disorder behavior that have been
recently noted in the literature as being common to eating disorder symptomatology. The
EDI – 3 is composed of 91 items that make up 12 scales: 3 eating disorder-specific scales
and 9 general psychological scales: drive for thinness, bulimia, body dissatisfaction,
ineffectiveness, perfectionism, interpersonal distrust, interoceptive awareness, and
maturity fears. The general psychological scales examine issues that are highly relevant
to eating disorders but not specific to them. The new EDI also has the advantage of
providing six composite scores; one is eating disorder-specific (Eating Disorder Risk),
and the other five are general constructs (Ineffectiveness, Interpersonal Problems,
Affective Problems, Overcontrol, General Psychological Maladjustment).
The development of the EDI was based on the assumption that disordered eating
is multidimensional in nature. In light of this, the EDI is composed of eight subscales that
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assess either attitudes and behaviors associated with eating and weight or personality and
psychological characteristics commonly found in eating-disordered individuals. The EDI
– 3 can provide normative information on eating-disordered individuals who are between
13 and 53. The EDI has been normed for all three DSM-IV-TR eating disorder diagnoses:
anorexia nervosa (restricting type and purging type), bulimia nervosa, and eating disorder
not otherwise specified. It has not been normed for obesity or binge eating disorder
(Psychological Assessment Resources, Inc.). The EDI – 3 has strong test-retest stability
coefficients. The median test-retest coefficient for the Eating Disorder Risk scales
composite is .95, and the median test-retest coefficient for the General Psychological
scales is .93 (Psychological Assessment Resources, Inc.).

Predictor Variables
Primary independent variables will be effect of therapist receipt of feedback,
response to treatment, and initial disease severity. A selected set of covariates will also be
assessed.

Feedback
To assess the effects of feedback to therapists on patient progress in treatment,
patients to whose therapists feedback is given will be compared to those about whom
feedback of progress is not made available. The treatment variable of feedback is
dichotomous and specifies participant randomization to either the experimental condition,
in which therapists were provided consistent feedback about patient progress in
treatment, or the control condition, in which no feedback was given to therapists. All
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patients will complete the OQ-45 on a regular basis over the course of their treatment,
and all OQ results will be recorded for each participant. However, only information for
patients randomized to the experimental group will be available for therapist review. For
patients assigned to the experimental group, therapists will receive computer-generated
feedback reports (Figure 6) the same day that the questionnaire is administered.

Initial Disease Severity
The Global Psychological Maladjustment Composite (GPMC) of the EDI-3 will
be used as the primary indicator of initial disease severity. Exploratory analyses will also
consider the extent to which initial severity on facets of Global Psychological
Maladjustment is predictive of treatment outcome. Specifically, the extent to which low
self-esteem, interpersonal problems, affective problems, and perfectionism are predictive
of treatment outcome will be assessed using the Ineffectiveness Composite, Interpersonal
Problems Composite, Affective Problems Composite, and Overcontrol Composite,
respectively.

Covariates
Previous investigations on eating disorder outcomes and/or treatment efficacy
have identified numerous variables that may impact treatment outcomes (Fairburn,
Cooper, Doll, & Welch, 1999; Fichter, Quadflieg, & Hedlund, 2006; Keel & Mitchell,
1997; Lindberg & Hjern, 2003; Quadflieg & Fichter, 2003; Steinhausen, 2002). For the
purposes of this study, three variables were identified following a review of the literature
as having the largest possible impact on treatment outcomes. These variables are eating
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disorder diagnosis (anorexia nervosa or bulimia), age of onset of eating disorder (age of
initial symptom manifestation), and duration of eating disorder (number of years since
symptom manifestation). In addition, the possible effects of therapist assignment will also
be assessed.

Outcome Variables
Primary dependent variables included (a) change in global psychological
dysfunction, (b) rate of change in global psychological dysfunction, and (c) length of
treatment period. The Outcome Questionnaire-45 (OQ-45) was used as the measure of
patient global psychological dysfunction. These three outcome variables were considered
across time in treatment. For purposes of these analyses, time was defined in terms of
number of OQ-45 check-ins, or “measurement occasions.” For this study, measurement
occasions of OQ-45 data were collected biweekly from patients (Monday and Thursday).
If a participant was missing data for a measurement occasion over the span of her
treatment, it was assumed that the data were missing at random. The outcome variables
were evaluated across periods of treatment, including over the entire treatment course
(i.e., time from treatment intake to discharge).

For Evaluation of Outcome for Total Course of Treatment
The OQ-45 data obtained across the participant treatment course yielded a
hierarchically nested data structure, with the participant’s biweekly OQ-45 scores nested
within the randomized feedback condition. Hierarchical linear modeling (HLM; Version
6.0.6; Raudenbush, Bryk, Cheong, & Congdon, 2004) was used to evaluate participant
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outcome for the total course of treatment. Following data cleaning and preparation for
analyses, within-participant regressions were performed, and then the resulting regression
coefficients were modeled as a function of the between-participant conditions,
assignment to a feedback or no-feedback condition. In other words, the HLM analyses
involved modeling the within-subjects (participant’s biweekly OQ-45 scores) variance at
Level 1 and between-subjects (or feedback condition) variance at Level 2 (Raudenbush &
Bryk, 2002). HLM was chosen for these analyses for its superior ability to manage data
that are collected longitudinally but at varying intervals and for its ability to manage
multiple covariance structures (Gibbons, Hedeker, Elkin, Waternaux, Kraemer,
Greenhouse, et al., 1993).
Hierarchical linear modeling typically consists of a level of within-subjects
factors (Level 1) nested in another level of between-subjects factors (Level 2). Level 1
represents the relationship between some measure of time (i.e., OQ Administration
Number) and the outcome variable for each participant (i.e., Total Score of OQ-45 for
each administration). While it is possible to have more than one outcome variable, for the
purposes of this investigation, only one outcome variable was identified to be analyzed.
The analysis of each Level 1 variable resulted in regression coefficients. The withinsubjects regression coefficients were estimated using the following equation:
OQ-45 Scoreij = β0j + β1j(OQ-45 Measurement Number)ij+ rij.
In this equation, OQ-45 Scoreij represents the participant’s final OQ-45 score at discharge
for participant j at OQ-45 measurement number I. For each individual j, the intercept is
represented by β0j and the within-subjects slope is represented by β1j.
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Level 2 variables of the HLM analysis are the invariant predictor variables that
define the relationship between the Level 1 variables as well as the estimated parameters
from the Level 1 intercepts and slopes. For example, the patients who participated in this
study were randomly assigned to either a control group or an experimental group. Group
membership is an invariant variable (e.g., once in an assigned group, patients were never
switched to the other group). As discussed in the literature review, therapist receipt of
feedback on patient progress has been shown to positively influence patient outcomes in
treatment (Harmon, Hawkins, Lambert, Slade, Whipple, 2005; Lambert, 2005; Lambert,
Whipple, Smart, Vermeersch, Nielsen, et al., 2001; Lambert, Whipple, Vermeersch,
Smart, Hawksin, et al., 2002; Lambert Ogles, 2009). If the covariate, or predictor,
variable is patient assignment to feedback condition, then the results of the Level 2
equation, in which the Level 1 outcome variable (TotalScore) and time variable
(SessNum) are nested, would represent the initial OQ score at intake and the rate of
change throughout treatment as influenced by patient assignment to a feedback condition.
Across-treatment change in global psychological dysfunction was defined as
β (i0- ij )i = β0j + β ij+ rij.
in which, for participant j, β0j is the OQ-45 score at baseline, β ij is the final OQ-45 score
before discharge, and β (i0-ij )i is the change between the scores at baseline and discharge.
Within-subjects error variance is represented by rij . Across-treatment rate of change in

global psychological dysfunction is defined as HLM slope from treatment entry (baseline
or β0j) to discharge (final measurement occasion or βij ). The length of treatment period is
defined as number of possible OQ-45 measurement occasions from treatment entry
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(baseline or β0j) to discharge (final OQ-45 score or βij).
Hierarchical linear modeling allows for the Level 1 regression coefficients to be
modeled at another level. The Level 1 regression coefficients were modeled at Level 2 as
a function of between-subjects differences based on the feedback condition and initial
level of global psychological dysfunction. This second level is represented by the
following equation:
β0j = γ00 + γ01j + γ02j + u0j
β1j = γ10 + γ11j + γ12j
In the between-subjects model, β0j through βij represent, respectively, the within-subjects
intercepts and slopes. The means of βij within-subjects regression coefficients are
represented by γ0s, covarying for the possible between-subjects effects of number of OQ
administrations and feedback condition. The errors of the β.js were represented by their
respective u.js and the variances are represented by the between-subjects error variances.

HLM Intercept-only Model
The intercept-only model, also known as the one-way ANOVA model with
random effects or unconditional model, is used to establish a baseline. The Level 1 and
Level 2 models are then compared to it. The intercept-only model equation is as follows:
β0j = β0 + ri
The intercept-only model revealed an intraclass correlation coefficient of .83. Thus, 83%
of the variance in OQ-45 scores was between-subjects (feedback versus no-feedback
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groups), and 17% of the variance in OQ-45 scores was at the student level. Because
variance existed at both levels of the data structure, predictors were added to each level
individually.
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Results
This chapter begins with a review of the mechanisms utilized for data preparation
and review. Next, the outcomes of the data screening and characteristics of the data
utilized in the Hierarchical Linear Models are presented. This chapter closes with stepby-step presentation of the results of each Hypothesis and Exploration Question.

Data Screening
All variables of interest were screened for multivariate assumptions. Variables
that presented as significantly skewed, leptokurtic, or platykurtic were transformed
logarithmically and screened again. Additionally, all variables were assessed for outliers.
For the purposes of this investigation, an outlier was defined as any variable with a zscore greater than 3.29. Three individuals were indicated to have outliers on at least one
measurement. Taking into consideration the already small sample size of this study,
alternate methods for managing the outliers without having to remove patients from the
data were considered. Based on the suggestion of Tabachnick and Fidell (1996), analyses
were run with and without the patients who had the outliers to assess the impact of the
outliers on the results. The outliers were not found to change the results of the analyses,
and therefore no patients were removed from this study due to possessing an outlying
variable within their data. The correlations between participant age, primary diagnosis
(AN or BN), total number of OQ administrations, OQ change score, and EDI-3
composite subscale Global Psychological Maladjustment variables were low, thus
alleviating concerns of multicollinearity (see Table 5). The correlations between
participant age, duration of eating disorder, and age eating disorder began were
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Table 5

Correlation Table of Variables Used in Analyses
Variable

Age
at
intake

Duration
of EDO

D

Participant Age at Intake
1.000
Duration of Eating
.729** 1.000
Disorder
Diagnosis
.233
.311*
1.000
Therapist Assignment
-.199
-.100
-.143
Age of Eating Disorder
.506** -.193
-.046
Onset
Length of Treatment
-.100
-.115
.070
Ineffectiveness
.152
.154
.195
Composite
Interpersonal Problems
.190
.120
.029
Composite
Affective Problems
.167
.154
.367**
Composite
Overcontrol Composite
.228
.242
-.011
Global Psychological
.187
.199
.323*
Maladjustment
Composite
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).

Therapist
assignment

Age
at
EDO
onset

Length of
treatment

IC

IPC

APC

1.000
-.209

1.000

-.196
-.048

.012
-.017

1.000
-.051

1.000

-.106

.108

.042

.754**

1.000

-.021

-.008

.013

.459**

.285*

1.000

.027
.015

-.082
-.062

.062
.004

.131
.568**

.159
.448**

.308*
.821**

OC

1.000
.510**

significant, as was expected. The correlations between the composite subscales of the
EDI-3 were also significant, as expected.
Data were screened for missing data, and six instances of missing data were
identified. Due to HLM not allowing for missing variables at Level 2 and age variables
being Level-2 data, mean substitution was used to replace missing data. Mean
substitution was utilized in order to preserve as much available data for analysis as
possible and, due to the low number of missing data points, the possibility of the mean
substitution resulting in a significant change in the values of the variables’ correlations
was low. This concern was addressed through examining correlation matrices before and
after implementing mean substitution for the missing data. There was not a significant
change between the correlation matrices.
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GPMC

1.000

Normality assumptions for all output variables were assessed through an
examination of each variable’s frequency plot of the distribution. Both nontransformed
and log-transformed variables appeared to be approximately normally distributed. Prior
to analyzing the data for HLM, each variable was assessed to ensure that it met the
primary assumptions of HLM. The two key assumptions are that the dependent variable
is normally distributed and that there is a linear relationship between the dependent and
independent variables (Raudenbush, 2004). The variable (TotalScore), representing the
unique total score of each OQ administration, violated the assumptions of normality (p <
.000). The variable was transformed using a loglinear transformation, which resulted in
the variable being normalized and meeting the criteria for normality (p > .05). To assess
the assumption of linearity, the session number (SessNum) variable was examined with
TotalScore as the dependent variable to assess for a linear relationship. SessNum was
chosen for this task as previous research has typically found number of treatment sessions
to be a predictor of better treatment outcomes (Howard et al., 1986). An examination of
the scatterplots representing the relationship between TotalScore and Sessnum indicated a
linear relationship between the variables. Therefore, the data met the key assumptions of
HLM.
The model-building process for the HLM began with an assessment of the
intercept model, which was composed of only the outcome variable (TotalScore) and the
time variable (SessNum). The intercept model indicated whether the patients experienced
change across the course of treatment. Had the analysis of the intercept shown there to be
no variability, no subsequent HLM analyses would have been conducted. The intercept
model indicated significant change across the course of treatment (see Figure 7 and Table
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6), and subsequent predictor variables were sequentially added to the model in order to
explain the remaining variance in the relationship between the Level 1 variables. As each
variable was added, the model was examined to assess for significant change in the
amount of residual error. If a variable resulted in a significant reduction of residual error,
it was thus assumed to account for a significant level of variance in the model. Variables
that did not explain variance in the model were removed. The resulting model was
composed of the independent variables feedback condition and the EDI-3 Global
Psychological Maladajustment Composite score. The final model was represented by the
following equation:
Level 1:

β0j = β0 + β1(SessNum) j + ri

Level 2:

β0j = γ00 + γ01(Feedback Group)j + γ02(EDI-3 GPMC Composite)j + u0j
β1j = γ10 + γ11(Feedback Group)j + γ12(EDI-3 GPMC Composite)j

Analyses of Hypotheses and Exploratory Questions
Hypothesis 1a
A paired-samples t test was conducted to compare subjects’ OQ scores at intake to
their OQ scores at the time of discharge as a measure of change in psychological
dysfunction. There was a significant difference between the OQ intake scores (M = 81.86,

SD = 24.72) and OQ discharge scores (M = 72.02, SD = 27.45); t(50) = 3.16, p = 0.003.
These results indicate that there was significant change in subjects’ intake and discharge
OQ scores. Specifically, these results suggest that global psychological dysfunction
significantly decreased over the course of treatment (Figure 7).
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The course of symptom change over treatment course was also assessed through
evaluation of significance of the HLM slope fixed-effects estimates. As indicated in
Table 7, patients started treatment with an average OQ score of 80.77 and became
significantly better by an average of 0.37 points per OQ-45 administration (p < .05).
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Figure 7. Mean change in OQ Score Across
Treatment Course for All Patients.

Table 6

HLM Parameters of Course of OQ-45 Scores Over Time in Treatment
for All Patients
Effect

Notation

Coefficient

SE

T-ratio

P-value

Intercept

β00

80.77

3.86

20.70

0.000

Slope

β10

-0.37

0.15

-2.58

0.016
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Hypothesis 1b
Interindividual differences in intraindividual change were assessed through an
evaluation of the random-effects estimates of the HLM slope at Level 1 of the
hierarchical analysis. Both the intercept and number of OQ administrations were found to
be reliable predictors of OQ-45 change scores; the reliability estimates equaled 0.97 and
0.84, respectively. The random-effects estimates of the HLM slope at Level 1 were
significant (p < .0005), and therefore the null hypothesis was rejected. The intraclass
correlation was examined with the following equation:

Yij = μ + αi + εij.
Significant interindividual differences in intraindividual change were noted; the pattern of
change in individual patients did vary relative to the sample level trajectory of change. In
other words, patients in the feedback group significantly varied in their change
trajectories from those in the nonfeedback group (interindividual variability) but had
similar change trajectories to other patients within their assigned feedback condition
(Müller & Büttner, 1994). Results of the intraclass correlation indicated that 86% of the
variance in patients’ change in global psychological dysfunction is attributed to the
between-subjects effect on mean TotalScore.
The results for Hypotheses 1a and 1b indicate that overall, participants’ OQ-45
scores varied across OQ administrations, indicating that patients did experience a change
in global psychological dysfunction during the course of treatment. These change patterns
were indicated both interindividually and intraindividually. The model is not complete,
however, as the within-subjects variance component is reported as significantly different
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from zero. Other predictor variables needed to be added to the model to account for the
remaining variance.

Hypothesis 2
A two-way repeated measures, within-subjects analysis of variance was conducted
to evaluate the effect of initial disease severity at the time of intake on patient treatment
outcomes. The within-subjects factors were the patient OQ scores at intake and discharge.
The EDI-3 Global Psychological Maladjustment Composite and total number of OQ
administrations were covariates in the analysis. The interaction and main effects were
tested using the multivariate criterion of Wilk’s Lambda (Λ ). Results of the repeated
measures ANOVA indicated that initial disease severity does not have a significant effect
on the average change of global psychological dysfunction at Time 1, intake, and Time 2,
discharge, Λ = .97, F(1, 47) = 1.62, p =.21, η2 = .03, nor does the number of OQ
administrations, Λ = .99, F(1, 47) = .52, p = .48, η2 = .01. These results indicate that
neither initial disease severity nor time in treatment have a significant relationship with a
patient’s change in global psychological dysfunction when one is examining patient
intake and discharge outcomes.
The EDI-3 Global Psychological Maladjustment Composite scale was not
indicated to have a significant effect on change in average global psychological
dysfunction between intake and discharge outcome scores when examined with repeatedmeasures ANOVA. An analysis of the intercepts-and-slopes as outcomes model utilized
GPMC to predict the Level 1 intercept and Level 1 slope of a patient’s global
psychological dysfunction through her course of treatment. GPMC was a significant
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Table 7

Final Estimations of Fixed Effects for the Conditional Model
Fixed Effect
Intercept β0

Coefficient

SE

T-Ratio

P-Value

Intercept1
GPMC
FB Group
Slope β1

83.24
1.60
-10.13

4.36
0.49
6.83

19.10
3.27
-1.48

0.000
0.002
0.144

Intercept2
GPMC
FB Group

-0.08
-0.01
-0.20

0.04
0.00
0.08

-2.06
-2.48
-2.39

0.039
0.014
0.017

predictor of the Level 1 intercept t(48) = 3.27, p =.002. Overall, initial disease severity
does significantly predict global psychological dysfunction at intake (Table 7).

Exploratory Question 2
A two-way repeated measures, within-subjects analysis of variance was conducted
to assess the extent to which self-esteem, interpersonal problems, affective problems, and
perfectionism moderate patient change in global psychological dysfunction between
intake and discharge. The within-subjects factors were the patient OQ scores at intake
and discharge. The EDI-3 composite scores for Ineffectiveness, Interpersonal Problems,
Affective Problems, and Overcontrol were analyzed as covariates. The interaction and
main effects were tested using the multivariate criterion of Wilk’s Lambda (Λ ). Results
of the repeated-measures ANOVA indicated EDI-3 composite scores for Ineffectiveness,
Λ = .99, F(1, 45) = .54, p = .47, η2 = .01, Interpersonal Problems, Λ = .99, F(1, 45) =
.19, p = .67, η2 = .00, Affective Problems, Λ = 1.00, F(1, 45) = .08, p = .78, η2 = .01, and
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Overcontrol, Λ = .99, F(1, 45) = .65, p = .42, η2 = .01, do not significantly moderate the
patient change in global psychological dysfunction between intake and discharge. These
results support the removal of these predictor variables from the HLM.

Hypothesis 3a
An ANOVA was conducted to determine whether feedback condition moderates
the patient change in global psychological dysfunction between intake and discharge.
Feedback condition was the primary predictor, and pre- to post-treatment OQ change
scores was the outcome variable. ANOVA results indicate that feedback condition does
not account for a significant amount of variance in the change in OQ scores administered
at intake and discharge F(1, 49) = 0.001, p = .98.

Hypothesis 3b
To determine if therapist receipt of feedback significantly predicts treatment
outcome, the Level 1 HLM slopes were examined. Level 1 of the HLM was represented
by the following equation:
OQ Score = β0 + β1(OQ Measurement Number) + r
and Level 2 was represented by the equation:
β0j = γ00 + γ01(Feedback Group)j + γ02(GPMC)j
β1j = γ10 + γ11(Feedback Group)j + γ12(GPMC)j.
Differences in the average rate of decrease in global psychological dysfunction between
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feedback conditions, after controlling for initial disease severity, were evaluated through
a comparison of t ratio analyses. The feedback condition was a significant predictor of
change in individual global psychological dysfunction across the course of treatment,

t(1309) = -2.39, p = .017. These results indicate that feedback condition can significantly
predict an individual’s change in global psychological dysfunction over the course of
treatment. Patients in the feedback condition improved their total OQ-45 score an average
of 0.20 per OQ-45 administration compared to patients not in the feedback condition.

Hypothesis 3c
The intercepts of the Level 2 HLM variables were examined using t-ratio analyses
to assess whether placement in the feedback condition impacted patient global
psychological dysfunction. The analysis of the relationship between feedback group
assignment and OQ-45 score at intake was not significant, t(48) = -10.13, p = 0.144
(Table 8). These results indicate that patients’ OQ-45 scores at intake were not
significantly different. Therefore, changes in the relationship between OQ-45 scores and
feedback condition that occur during the course of treatment would be related to the
impact of feedback group assignment and not caused by the initial assignment to either
feedback condition.

Hypothesis 4
Variation in total treatment duration at Valenta attributable to therapist receipt of
treatment response feedback, beyond the variation accounted for by disease severity, was
assessed by an analysis of covariance (ANCOVA) with feedback condition as the
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primary predictor, EDI global psychological maladjustment as a continuous covariate,
and total number of OQ administrations as the dependent variable. The ANCOVA was
significant F(2, 48) = 4.18, p = .05. The feedback condition was significant after
controlling for EDI-3 global psychological maladjustment. The hypothesis that, after
consideration of initial disease severity, patients whose therapists receive feedback have
shorter treatment duration was not confirmed, however. Results of the ANCOVA indicate
that patients whose therapists receive feedback have a longer course of treatment than do
patients whose therapists do not receive feedback (Figure 8).

Figure 8. Mean Number of Total OQ Administrations by Feedback Condition.
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Discussion

This final chapter of this investigation into the impact of individually tailored
service allocation opens up with a review of the importance of identifying for effective
treatments for eating disorders. A discussion of the results of this investigation and their
meaning and possible significance for the successful treatment of eating disorders follors.
The chapter closes with important methodological considerations for this research
investigations and, finally, closes with discussion of future areas for research relating to
the problems presented herein.
This investigation was designed to evaluate the impact of Individually Tailored
Service Allocation on eating disorder treatment outcomes. The design and
implementation of successful eating disorder treatment rely not only upon understanding
the risk factors and etiology of these life-destroying disorders, but also on examining the
symptom course, particularly within a treatment setting. This is particularly true given the
complexity of the many varied risk factors that may lead to the development of an eating
disorder. As indicated by the breadth of information included in the literature review for
this investigation, there have been hundreds of studies examining risk factors, etiologies,
treatment strategies, treatment outcomes, and a multitude of combinations of these
factors. One oft-overlooked entity, though, is the course of patient symptom presentation
throughout the course of treatment.
As highlighted earlier, a wide range of treatment strategies for eating disorders
exist, but the effectiveness of the treatment strategies remains low. Some researchers
posit that as few as 50% of individuals with bulimia nervosa (Agras, 1993; Kordy, 2002;
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Wilson, 1996) and 40% of individuals with anorexia nervosa (Kordy, 2002) will reach
recovery. Such low numbers prove further investigation into existing treatment methods
is needed. Complications with treatment are often related to the difficulty in defining the
etiology of eating disorders as well as the role of societal and cultural factors.
Researchers appear to have reached consensus regarding the importance of cognitions
and interpersonal relationships in the maintenance of bulimia. However, many clinicians
and researchers also report reaching an impasse when trying to identify which forms of
therapy are most appropriate for anorexia. For example, Nevonen and Broberg (2006)
suggested that IPT is more effective with bulimic individuals struggling with impulsivity
and affective instability, whereas CBT is the treatment of choice for those whose EDO
has an origin in body image, eating concerns, and a focus on weight.
Unfortunately, these different aspects of an individual’s eating disorder may not
emerge until late in treatment. Tobin and associates (2007) reported that 98% of
clinicians who specialize in the treatment of eating disorders use an eclectic treatment
approach in lieu of a standardized treatment manual. Empirically validated outcome
strategies are almost impossible to assess in such a varied and diverse treatment arena.
Yet with an almost 50% recovery rate for individuals with an eating disorder, it is clear
that someone is doing something right in terms of eating disorder treatment. The real
dilemma may not be which standardized treatment strategy a clinic or provider should
adopt as the primary course of eating disorder treatment; instead, it may be how a
clinician appropriately assesses which individual treatment strategies will most
effectively treat this unique patient’s eating disorders. Thus far, current research has only
focused on outcome data or compared symptom level at intake with that at discharge.
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Both strategies merely highlight success or failure in treatment and do not allow for
clinician intervention based on the collected outcome data.
The results of this study indicate that variability in levels of global psychological
dysfunction throughout the course of treatment appear to be the norm, rather than an
exception, and this variability is related to eating disorder treatment outcomes.
Interestingly, despite the widely documented recognition of several key risk factors for
eating disorders as well as key predictors of treatment outcome, only initial global
psychological maladjustment and feedback group assignment were indicated as
significant predictors of treatment outcomes.
Global psychological maladjustment as measured by the global composite scale of
the EDI-3 was a resilient predictor of treatment outcomes. Membership in the feedback
group also had a significant effect on treatment, particularly over the course of treatment.
Therapists may have been primed by patients’ scores on the GPMC and the correlating
intake OQ-45 scores, which highlighted the unique psychological maladjustment and
dysfunction, respectively, for each patient. This priming could have led to greater
attunement to the patient’s symptom presentation and thus enhanced the possibility of a
positive treatment outcome. Patients whose therapists did not receive biweekly outcome
reports on their treatment progress may not have benefited from the same level of
awareness provided by the global psychological maladjustment and intake OQ-45 results,
as there were not regular objective reminders of the patient’s current psychological status.
This current investigation is relevant to previous research, as it clearly indicates
that Individually Tailored Service Allocation serves to enhance treatment outcomes in an
eating disorder treatment center. These results challenge popular notions that treatment
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strategies need to be manualized and streamlined in order to not only get the best results,
but also identify key variables for predicting treatment outcomes. Given the widely
varied and complex etiology of an eating disorder, it is not surprising that treatment
trajectory and treatment outcomes vary as a function of intraindividual differences within
a group, or interindividual, context. Each individual maintained a unique treatment course
with widely varying scores on the OQ-45, yet all participants in the feedback condition
followed the same treatment course—in other words, participants had unique treatment
trajectories as indicated by the OQ-45 scores across treatment course but had
significantly similar treatment trajectories within their assigned feedback condition.
The current study provides compelling evidence to suggest that eating disorder
symptom manifestation and symptom regression do not follow a stable, linear course
throughout treatment. Recognizing this variability and implementing treatment strategies
specific to the unique symptom presentation of each patient appear to be a critical in
reducing global psychological dysfunction. Counter to the existing research literature
(Kordy, Hannöver, & Richard, 2001; Kordy & Lutz, 1995), the current study found that
when outcome data are examined in a purely linear fashion, important fluctuations in
treatment course are lost.
As highlighted by the notable discrepancy in the results for Hypothesis 2, the
choice of an appropriate statistical procedure has an irrefutable ability to drastically shift
the outcome of an investigation. Similarly, the choice of treatment methodology and level
of Individually Tailored Service Allocation have the irrefutable ability to drastically shift
treatment outcomes, as clearly indicated by the results of the investigation. The notion
that eating disorder treatment is a linear process is clearly disputed by the results for
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Hypothesis 2. Results examining the impact of global psychological maladjustment on
the change in OQ scores from intake to discharge were not significant (p = .21), nor was
number of OQ administrations (p = .48). According to the results of the within-subjects,
repeated-measures ANOVA, neither initial disease severity nor time in treatment have a
significant relationship with a patient’s change in global psychological dysfunction when
one is examining patient intake and discharge outcomes. This statistical procedure
represents a one-size-fits-all-approach to data examination, which is unfortunately the
approach taken by managed care providers and insurance agencies when parsing out
coverage for eating disorder treatment. Successful eating disorder treatment may hinge on
regularly examining patient progress throughout the course of treatment. Typically,
eating disorder treatment is designed to meet the standard demanded by insurance
companies or by the treatment providers. If, however, patients do have unique treatment
trajectories, then treatment does need to be tailored to match each patient (Agras et al.,
2001), allowing for the most effective use of therapeutic resources and the most
beneficial treatment. The results for Hypothesis 4 provide support for individually
tailored treatment allocation. These findings indicated that patients in the therapist
feedback condition actually had a longer treatment course than those in the nonfeedback
condition. This outcome is not likely to be looked upon favorably by healthcare
organizations that are constantly seeking to reduce costs related to patient care. It will be
important for researchers to continue to build the case that while longer treatment is more
costly in the short run, the costs will be significantly lower if treatment is successful and
future partial hospitalization or higher level care is avoided in the future.
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Methodological Considerations
There are several limitations to this study that warrant discussion. First, with a
small sample size and lack of power, it may not have been possible to detect the
psychological predictors that significantly predict rapidity of weight gain. Additionally,
this study included a mostly homogenous sample of participants with regard to gender
and ethnicity. While this sample is relatively consistent with those of other studies that
have evaluated eating disorder populations, the results of this study are not generalizable
to males and people of non-Caucasian ethnicities. Furthermore, all psychological
measures consisted exclusively of self-report questionnaires. Due to the denial and
ambivalence involved in this disorder, participants may have underreported their
symptoms and difficulties. While patients were assured that their measures would remain
confidential, they may have responded with the belief that their answers could have a
possible impact on the length of time they spend in treatment.
Another methodological limitation of this study pertains to the use of treatment
duration as a measure of outcome. Although Valenta delineated similar treatment goals
and discharge criteria for patients, a patient’s length of time in treatment is subject to
external factors such as insurance, family concerns, financial stress, etc. Therefore,
treatment duration is dependent on the physical and psychological health of the patient
and includes external variables that are impossible to control methodologically. This
investigation did not examine external factors that could have impacted treatment
duration.
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Areas for Future Research
It is recommended that the current study be continued in order to increase sample
size and strengthen the results of the investigation. It is the hope of this researcher that
upon completion of this investigation, the results are utilized to inform treatment
practices and support patients in receiving appropriate care. In particular, a significant
amount of time and resources are utilized with the hope or aiding individuals with an
eating disorder to achieve remission and recovery. The results of Hypothesis 4, which
indicated that patients in the therapist feedback condition actually had a longer treatment
course than those in the nonfeedback condition, are particularly provocative. This
outcome is not likely to warrant applause from healthcare organizations that are
constantly seeking to reduce costs related to patient care but may illuminate why current
remission and reocovery rates are so dismal. Future research ought to continue to build
the case that while longer treatment is more costly in the short run, in consideration of
long-term outcomes, the costs will be significantly lower if treatment is successful and
future partial hospitalization or higher level care is not warranted.
The results of this investigation are easily generalized to the demographic
population commonly served in eating-disorder treatment programs. It is important for
future research to evaluate how treatment outcomes may differ in a population of
minorities or males with eating disorders. A more diverse sample will also enable
researchers to examine additional cultural and societal factors not considered in this
investigation and their impact on eating-disorder treatment outcomes. Important
psychological differences between ethnicity and gender could be vital in determining
methods of eating-disorder intervention and treatment focus.
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The data collected in this investigation adequately assessed patient progress
throughout the course of treatment. It would be fruitful to examine the subscales of the
OQ-45 throughout the course of treatment in order to assess for emerging interpersonal
concerns, social role perceptions, and symptom distress (a measure of depression and
anxiety; Lambert, Hansen, et al., 2001). This would provide both clinicians and
researchers with additional information needed to examine the relationships between
these different facets and treatment outcomes. Examining the OQ-45 subscales
throughout the course of treatment may also provide clarification as to why several of the
variables that have been previously found to significantly predict treatment outcomes
(i.e., age of eating disorder onset, duration of eating disorder, etc.) were not found to be
significant in this model. Along these same lines, the OQ-45 is a general measure of
global psychological dysfunction and is not an outcome measure specific to the
assessment of eating-disorder symptoms. Using a standardized measure for assessing
eating-disorder symptoms at regular intervals during the course of treatment along with
the OQ-45 would provide additional, crucial information about the change trajectory of
eating-disorder symptoms throughout the treatment course as well as serve as another
invaluable resource for clinical intervention.
Future research could also involve continuing to follow a patient’s treatment
using the OQ-45 after she has completed treatment with Valenta and stepped down into a
lower level of care such as outpatient individual therapy. Collecting this additional
information, post-partial hospitalization, would enable researchers to assess changes in
additional psychological variables as well as track whether improvements made during
the course of treatment are maintained.
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Finally, future research should also take into consideration the effects of other
variables that have been defined in the literature as predicting treatment outcome. For
example, 11 variables have been identified as primary predictors of treatment outcomes
for individuals with anorexia nervosa: duration of the eating disorder, age of onset,
family of origin, age at onset of menstruation, sexual problems, psychiatric comorbidity,
perfectionism, impulsivity, self-evaluation, extroversion, and low body weight (Fairburn,
Cooper, Doll, & Welch, 1999; Keel & Mitchell, 1997; Lindberg & Hjern, 2003;
Quadflieg & Fichter, 2003; Steinhausen, 2002). These variables could possibly be
assessed in conjunction with the OQ-45 biweekly administration or, should that prove too
burdensome, at both intake and discharge, thus allowing for an assessment of overall
change in symptom presentation throughout treatment.

106

References

Agras, W. S., Walsh, B. T., Fairburn, C. G., Wilson, G. T., & Kraemer, H. C. (2000). A
multicenter comparison of cognitive-behavioral therapy and interpersonal
psychotherapy for bulimia nervosa. Archives of General Psychiatry, 57, 459–466.
Ainsworth, C., Waller, G., & Kennedy, F. (2002). Threat processing in women with
bulimia. Clinical Psychology Review, 22, 1155–1178.
Alger, S. A., Schwalbers, M. D., Bigaouette, J. M., Michalek, A. V., & Howard L. J.
(1991). Effect of a tricyclic antidepressant and opiate antagonist on binge-eating
in normoweight bulimic and obese, binge-eating subjects. American Journal of
Clinical Nutrition, 53, 865–871.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental
disorders (4th ed.). Washington, DC: Author.
American Psychiatric Association Work Group on Eating Disorders. (2000). Practice
guideline for the treatment of patients with eating disorders (revision). American
Journal of Psychiatry, 157(1 Suppl.): 1–39.
Anderluh, M. B., Tchanturia, K., Rabe-Hesketh, S., & Treasure, J. (2003). Childhood
obsessive-compulsive personality traits in adult women with eating disorders:
Defining a broader eating disorder phenotype. American Journal of Psychiatry
160, 242–247.
Andersen, A. E., Bowers, W. A., & Watson, T. (2001). A slimming program for eating
disorders not otherwise specified: Reconceptualizing a confusing, residual
diagnostic category. Psychiatric Clinics of North America, 24, 271–280.
Attia, E., & Schroeder, L. (2005). Pharmacologic treatment of anorexia nervosa: Where
do we go from here? International Journal of Eating Disorders, 37, S60–S63.
Audenaert, K., Van Laere, K., Dumont, F., Vervaet, M., Goethals, I., Slegers, G., et al.
(2003). Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
Journal of Nuclear Medicine, 44, 163–169.
Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory.
Englewood Cliffs, NJ: Prentice Hall.
Barnes, N. M., & Sharp, T. (1999) A review of central 5-HT receptors and their function.
Neuropharmacology, 38, 1083–1152.
Barr, L. C., Goodman, W. K., Price, L. H., McDougle, C. J., & Charney, D. S. (1992).
The serotonin hypothesis of obsessive compulsive disorder: Implications of

107

pharmacologic challenge studies. Journal of Clinical Psychiatry, 53(Suppl.), 17–
28.
Becker, A. E., Burwell, R. A., Gilman, S. E., Herzog, D. B., & Hamburg, P. (2002).
Eating behaviors and attitudes following prolonged exposure to television among
ethnic Fijian adolescent girls. British Journal of Psychiatry 180, 509–514.
Berrettini, W. (2004). The genetics of eating disorders. Psychiatry, 3, 18–25.
Beumont, P. J., Russel, J. D., Touyz, S. W., Buckley, C., Lowinger, K., Talbot, P., &
Johnson, G. F. (1997). Intensive nutritional counseling in bulimia nervosa: A role
for supplementation with fluoxetine. Australian and New Zealand Journal of
Psychiatry, 31, 514–524.
Birmingham, C. L., Su, J., Hlynsky, J. A., Goldner, E. M., & Gao, M. (2005). The
mortality rate from anorexia nervosa. International Journal of Eating Disorders,
38, 143–146.
Bodnar, R. J. (2004). Endogenous opioids and feeding behavior: A 30-year historical
perspective. PeptidesI, 25, 697–725.
Botta, R. A. (1999). Television images and adolescent girls’ body image disturbance.
Journal of Communication, 49, 22–41.
Byrk, A., & Raudenbush, S. (1992). Hierarchical linear models. Thousand Oaks, CA:
Sage.
Cardinal, R. N., Parkinson, J. A., Hall, J., & Everitt, B. J. (2002). Emotion and
motivation: The role of the amygdala, ventral striatum, and prefrontal cortex.
Neuroscience & Biobehavioral Reviews, 26, 321–352.
Carter, F. A., Bulik, C. M., Lawson, R. H., Sullivan, P. F., & Wilson, J. S. (1997). Effect
of mood and food cues on information processing in women with bulimia
nervosa. Behavior Change, 14, 113–120.
Cash, T. F. (1997). The body image workbook: An 8-step program for learning to like
your looks. Oakland, CA: New Harbinger.
Chavez, M., & Insel, T. R. (2007). Eating disorders: National Institute of Mental Health's
perspective. American Psychologist, 62, 159–166.
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied multiple
regression/correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ:
Lawrence Erlbaum.
Connan, F., Campbell, I. C., Katzman, M., Lightman, S. L., & Treasure, J. (2003). A
neurodevelopmental model for anorexia nervosa. Physiology & Behavior, 79, 13–
24.
108

Crow, S. J., Agras, W. S., Halmi, K., Mitchell, J. E., & Kraemer, H. C. (2002). Full
syndromal versus subthreshold anorexia nervosa, bulimia nervosa, and binge
eating disorder: A multicenter study. International Journal of Eating Disorders,
32, 309–318.
Cusumano, D. L., & Thompson, J. K. (1997). Body image and shape ideals in magazines:
Exposure, awareness, and internalization. Sex Roles, 37, 701–721.
Dare, C., Eisler, I., Russell, G., Treasure, J., & Dodge, L. (2001). Psychological therapies
for adults with anorexia nervosa: Randomized controlled trial of outpatient
treatments. British Journal of Psychiatry, 178, 216–221.
Davis, C. & Woodside, D. B. (2002). Sensitivity to the rewarding effects of food and
exercise in the eating disorders. Comprehensive Psychiatry, 43, 189–194.
Delparigi, A., Chen, K., Salbe, A. D., Reiman, E. M., & Tataranni, P. A. (2005). Sensory
experience of food and obesity: A positron emission tomography study of the
brain regions affected by tasting a liquid meal after a prolonged fast. Neuroimage,
24, 436–443.
Delvenne, V., Lotstra, F., Goldman, S., Biver, F., De Maertelaer, V., & AppelboomFondu, J. (1995). Brain hypometabolism of glucose in anorexia nervosa: A PET
scan study. Biological Psychiatry, 37, 161–169.
Di Chiara, G. (1999). Drug addiction as dopamine-dependent associative learning
disorder, European Journal of Pharmacology, 375, 13–30.
Drobes, J. D., Miller, E. J., Hillman, C. H., Bradley, M. M., Cuthbert, B. N., & Lang, P.
J. (2001). Food deprivation and emotional reactions to food cues: Implications for
eating disorders. Biological Psychiatry, 57, 153–177.
Dykens, E. M., & Gerrard, M. (1986). Psychological profiles of purging bulimics, repeat
dieters, and controls. Journal of Consulting and Clinical Psychology, 283–288.
Eisler, I., Dare, C., Hodes, M., Russell, G., Dodge, E., & Le Grange, D. (2000). Family
therapy for adolescent anorexia nervosa: The result of a controlled comparison of
two family interventions. Journal of Child Psychology and Psychiatry, 41, 727–
736.
Erdfelder, E., Faul, F., & Buchner, A. (1996). GPOWER: A general power analysis
program. Behavior Research Methods, Instruments & Computers, 28, 1–11.
Erdfelder, E., Faul, F., & Buchner, A. (2005). Power analysis for categorical methods. In
B. S. Everitt & D. C. Howell (Eds.), Encyclopedia of statistics in behavioral
science (pp. 1565–1570). Chichester, UK: John Wiley & Sons, Ltd.
Fairburn, C. G., Cooper, Z., Doll, H. A., O’Connor, M. E., Bohn, K., Hawker, D. M., et
al. (2008). Transdiagnostic cognitive–behavioral therapy for patients with eating
109

disorders: A two-site trial with 60-week follow-up. American Journal of
Psychiatry, 166(3),1–9.
Fairburn, C.G. & Harrison, P.J. (2003). Eating disorders. Lancet, 361, 407–416.
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible
statistical power analysis for the social, behavioral, and biomedical sciences.
Behavior Research Methods, 39, 175–191.
Fluoxetine Bulimia Nervosa Collaborative Study Group. (1992). Fluoxetine in the
treatment of bulimia nervosa: A multicenter, placebo-controlled, double-blind
trial. Archives of General Psychiatry, 49, 139–147.
Fox, P. T., Raichle, M. E., Mintun, M. A., & Dence, C. (1988). Nonoxidative glucose
consumption during focal physiologic neural activity. Science, 241, 462–464.
Frank, G. K., Bailer, U. F., Shannan, E. H., Drevets, W., Meltzer, C. C., Price, J. C., et al.
Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa
measured by positron emission tomography and [11C] raclopride. Biological
Psychiatry, in press.
Frank, G. K., Kaye, W. H., Greer, P., Meltzer, C. C., & Price, J. C. (2000). Regional
cerebral blood flow after recovery from bulimia nervosa. Psychiatry Research:
Neuroimaging, 100, 31–39.
Franko, D. L., Wonderlich, S. A., Little, D., & Herzog, D. B. (2004). Diagnosis and
classification of eating disorders: What's new. In J. K. Thompson (Ed.),
Handbook of eating disorders and obesity (pp. 58–80). New York: Wiley.
Frederickson, B. L., & Roberts, T. A. (1997). Objectification theory: Towards
understanding women’s lived experiences and mental health risks. Psychology of
Women Quarterly, 21, 173–206.
Friederich, H. C., Kumari, V., Uher, R., Riga, M., Campbell, I., Herzog, W., et al. (2005).
Motivational-emotional responses to food, body image and emotional cues in
eating disorders, a startle reflex paradigm.
Frith, U. (1989). Autism: Explaining the enigma. Oxford: Blackwell Science.
Furumoto, L., & Keating, K. M. (1995). Trends and issues in theoretical psychology. In I.
Lubek, R. van Hezewijk, G. Pheterson, & C. W. Tolman (Eds.), Problems of
Theoretical Psychology, pp. 105–111). New York, NY: Springer Publishing Co.
Gabbard, G. (2000). Psychodynamic psychiatry in clinical practice. Washington, DC:
American Psychiatric Press.
Garner, D. (1991). Eating Disorder Inventory-2: Professional manual. Odessa, FL:
Psychological Assessment Resources, Inc.
110

Garner, D. M. (2004). Eating Disorder Inventory-3: Professional manual. Odessa, FL:
Psychological Assessment Resources.
Gibbons, R. D., Hedeker, D. R., Elkin, I., Waternaux, C., Kraemer, H. C., Greenhouse, J.
B., et al. (1993). Some conceptual and statistical issues in analysis of longitudinal
psychiatric data. Archives of General Psychiatry, 50, 739–750.
Gillberg, C., Rastam, M., & Gillberg, I. C. (1994). Anorexia nervosa: Physical health and
neurodevelopment at 16 and 21 years. Developmental Medicine & Child
Neurology, 36, 567–575.
Goethals, I., Vervaet, M., Audenaert, K., Van de Wiele, C., Ham H., Vandecapelle, M.,
et al. (2004). Comparison of cortical 5-HT2A receptor binding in bulimia nervosa
patients and healthy volunteers, American Journal of Psychiatry, 161(10), 1916–
1918.
Goldbloom, D. S., Olmsted, M., Davis, R., Clewes, J., Heinmaa, M., Rockert, W., et al.
(1997). A randomized controlled trial of fluoxetine and cognitive behavioral
therapy for bulimia nervosa: Short-term outcome. Behavioral Research and
Therapy, 35, 803–811.
Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., & Rampey, A. H., Jr.
(1995). Long-term fluoxetine treatment of bulimia nervosa: Fluoxetine Bulimia
Nervosa Research Group. British Journal of Psychiatry, 166, 660–666.
Gordon, R. A. (2000). Eating disorders: Anatomy of a social epidemic (2nd ed.).
Cambridge: Blackwell.
Grahame-Smith, D. G. (1992). Serotonin in affective disorders. International Clinical
Psychopharmacology, 6(Suppl. 4), 5–13.
Green, M. W., Elliman, N. A., Wakeling, A., & Rogers, P. J. (1996). Cognitive
functioning, weight change, and therapy in anorexia nervosa. Journal of
Psychiatric Research, 30, 401–410.
Groesz,, L. M., Levine, M. P., & Murnen, S. K. (2002). The effect of experimental
presentation of thin media images on body satisfaction: A meta-analytic review.
International Journal of Eating Disorders 31, 1–16.
Gross, H. A., Ebert, M. H., Faden, V. B., et al. (1981). A double-blind controlled trial of
lithium carbonate in primary anorexia nervosa. Journal of Clinical
Psychopharmacology 1, 376.
Harrison, K., & Cantor, J. (1997). The relationship between media and consumption and
eating disorders. Journal of Communication, 47, 40–67.

111

Hatsukami, D., Owen, P., Pyle, R., & Mitchell, J. (1982). Similarities and differences on
the MMPI between women with bulimia and women with alcohol or drug abuse
problems. Addictive Behaviors, 7, 435–439.
Hernandez, L., & Hoebel, B. G. (1988). Food reward and cocaine increase extracellular
dopamine in the nucleus accumbens as measured by microdialysis. Life Science,
42, 1705–1712.
Herzog, D. B., & Delinsky, S. S. (2001).Classification of eating disorders. In R. H.
Striegel-Moore & L. Smolak (Eds.), Eating disorders: Innovative directions in
research and practice (pp. 31–50).Washington, DC: American Psychological
Association.
Hirano, H., Tomura, N., Okane, K., Watarai, J., & Tashiro, T. (1999). Changes in
cerebral blood flow in bulimia nervosa. Journal of Computer Assisted
Tomography, 23, 280–282.
Holtkamp, K., Konrad, K., Kaiser, N., Ploenes, Y., Heussen, N., Grzella, I., & HerpertzDahlmann, B. (2005). A retrospective study of SSRI treatment in adolescent
anorexia nervosa: Insufficient evidence for efficacy. Journal of Psychiatry
Research, 39, 303–310.
Howard, K. I., Kopta, S. M., Krause, M. S., & Orlinsky, D. E. (1986). The dose-effect
relationship in psychotherapy. American Psychologist, 41, 1159–1164.
Howard, K. I., Lueger, R. J., Maling, M. S., & Martinovich, Z. (1993). A phase model
of psychotherapy: Causal mediation of outcome. Journal of Consulting and
Clinical Psychology, 61, 678–685.
Howard, K. I., Moras, K., Brill, P. L., Martinovich, Z., & Lutz, W. (1996). Evaluation of
psychotherapy: Efficacy, effectiveness, and patient progress. American
Psychologist, 51, 1059–1064.
Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007). The prevalence and
correlates of eating disorders in the national comorbidity survey replication.
Biological Psychiatry, 61, 348–358.
Jansen, A. (1990). Binge eating: Notes and data. Unpublished doctoral dissertation,
Limburg University, Maastricht.
Katzman, D. K., Lambe, E. K., Mikulis, D. J., Ridgley, J. N., Goldbloom, D. S., &
Zipursky, R. B. (1996). Cerebral gray matter and white matter volume deficits in
adolescent girls with anorexia nervosa. Journal of Pediatrics, 129,794–803.
Katzman, M. A., & Lee, S. (1997). Beyond body image: The integration of feminist and
transcultural theories in the understanding of self starvation. International Journal
of Eating Disorders, 22, 385–394.

112

Kaye, W. H. (1999). The new biology of anorexia and bulimia nervosa: Implications for
advances in treatment. European Eating Disorders Review, 7,157–161.
Kaye, W. H., Bailer, U. F., Frank, G. K., Wagner, A., & Henry, S. E. (2005). Brain
imaging of serotonin after recovery from anorexia and bulimia nervosa.
Physiology and Behavior, 86, 15–17.
Kaye, W. H., Bulik, C., Thornton, L., Barbarich, N., & Masters, K. (2004). Comorbidity
of anxiety disorders with anorexia and bulimia nervosa. American Journal of
Psychiatry, 161, 2215–2221.
Kaye, W. H., Frank, G. K., Bailer, U. F. Henry, S. E., Meltzer, C. C., Price, J. C., et al.
(2005). Serotonin alterations in anorexia and bulimia nervosa: New insights from
imaging studies. Physiology and Behavior, 85, 73–81.
Keel, P. K., & Klump, K. L. (2003). Are eating disorders culture-bound syndromes?
Implications for conceptualizing their etiology. Psychological Bulletin, 129, 747–
769.
Kelley, A. E. (2004). Memory and addiction: Shared neural circuitry and molecular
mechanisms. Neuron, 44, 161–179.
Kendall, P. C. (1998). Directing misperceptions: Researching the issues facing manualbased treatments. Clinical Psychology: Science and Practice, 5, 396–399.
Kennan, R. P., Takahashi, K., Pan, C., Shamoon, H., & Pan, J. W. (2005). Human
cerebral blood flow and metabolism in acute insulin induced hypoglycemia.
Journal of Cerebral Blood Flow Metabolism, 25, 527–534.
King, B. M. (2006). The rise, fall, and resurrection of the ventromedial hypothalamus
regulation of feeding behavior and body weight. Physiology and Behavior, 87,
221–244.
Knable, M. (2001). Topiramate for bulimia nervosa in epilepsy. American Journal of
Psychiatry, 158, 322–323.
Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and
allostasis. Neuropsychopharmacology, 24, 97–129.
Kordy, H., Hannöver, W., & Richard, M. (2001). Computer-assisted feedback-driven
quality management for psychotherapy: The Stuttgart–Heidelberg Model. Journal
of Consulting and Clinical Psychology, 69, 173–183.
Kordy, H., Haug, S., & Percevic, R. (2006). Patients differ—A plea for Individually
Tailored Service Allocation. European Eating Disorders Review, 14, 1–7.
Kordy, H., & Lutz, W. (1995). Das Heidelberger Modell: Von der Qualitätskontrolle zum
Qualitäts management stationärer Psychotherapie [The Heidelberg model: From

113

quality control to quality management in inpatient psychotherapy by computer
assistance]. Psychotherapie Forum, 3, 197–206.
Kordy, H., Kramer, B., Palmer, R. L., Papezova, H., Pellet, J., Richard, M., et al. (2002).
Remission, recovery, relapse, and recurrence in eating disorders:
Conceptualization and illustration of a validation strategy. Journal of Clinical
Psychology, 58, 833–846.
Kordy, H., Matthias, R., Anke, H., Murphy, F. (1999). A computer assisted eating
disorder- specific quality management system: EQUAL-TREAT. European
Eating Disorders Review, 7, 239-258.
Krüger, S., & Kennedy, S. H. (2000). Psychopharmacotherapy of anorexia nervosa,
bulimia nervosa, and binge-eating disorder. Journal of Psychiatry &
Neuroscience, 25, 497–508.
Kucharska-Pietura, K., Nickolaou, V., Marsiak, M., & Treasure, J. (2004). The
recognition of emotion in the faces and voice of anorexia nervosa. International
Journal of Eating Disorders, 35, 42–47.
Lambert, M. J. (2001). The status of empirically supported therapies: Comment on
Westen and Morrison’s (2001) multidimensional meta-analysis. Journal of
Consulting and Clinical Psychology, 69, 910–913.
Lambert, M. J. (2005). Emerging methods for providing clinicians with timely feedback
on effective treatment: An introduction. Journal of Clinical Psychology: In
Session,
61, 141–144.
Lambert, M. J., & Bergin, A. E. (1994). The effectiveness in psychotherapy. In A. E.
Bergin & S. L. Garfield (Eds.), Handbook of psychotherapy and behavior change.
New York, NY: Wiley.
Lambert, M. J., DeJulio, S. J., & Stein, D. M. (1978). Therapist interpersonal skills:
Process, outcome, methodological considerations, and recommendations for
future research . Psychological Bulletin, 85, 467–489 .
Lambert, M. J., & Finch, A. E. (1999). The outcome questionnaire. In M. E. Maurish
(Ed.), The use of psychological testing for treatment planning and outcome
assessment (2nd ed., pp. 831–870). Mahwah, NJ: Erlbaum.
Lambert, M. J., Hansen, N. B., & Finch, A. E. (2001). Patient-focused research: Using
patient outcome data to enhance treatment effects. Journal of Consulting and
Clinical Psychology, 69, 159–172.
Lambert, M. J., Harmon, C., Slade, K., Whipple, J. L., & Hawkins, E. J. (2005).
Providing feedback to psychotherapists on their patients’ progress: Clinical results
and practice suggestions. Journal of Clinical Psychology, 61, 165–174.
114

Lambert, M. J., Whipple, J. L., Hawkins, E. J., Vermeersch, D. A., Nielsen, S. L., &
Smart, D. W. (2003). Is it time for clinicians to routinely track patient outcome? A
meta analysis. Clinical Psychology: Science and Practice, 10, 288–301.
Lambert, M. J., Whipple, J. L., Smart, D. W., Vermeersch, D. A., Nielsen, S. L., &
Hawkins, E. J. (2001). The effects of providing therapists with feedback on
patient progress during psychotherapy: Are outcomes enhanced? Psychotherapy
Research, 11, 49–68.
La Via, M. C., Gray, N., & Kaye, W. H. (2000). Case reports of olanzapine treatment of
anorexia nervosa. International Journal of Eating Disorders, 27, 363.
Levine, A. S., & Billington, C. J. (2004). Opioids as agents of reward-related feeding: A
consideration of the evidence. Physiology and Behavior, 82, 57–61.
Levine, M. P., & Smolak, L. (1998). The mass media and disordered eating: Implications
for primary prevention. In W. Vandereycken & G. Noordenbos (Eds.), The
prevention of eating disorders (pp. 23–56). London: Athlone Press.
Levine, M. P., & Smolak, L. (2006). The prevention of eating problems and eating
disorders. Mahwah, NJ: Lawrence Erlbaum.
Lewinsohn, P. M., Striegel-Moore, R. H., & Seeley, J. R. (2000). Epidemiology and
natural course of eating disorders in young women from adolescence to young
adulthood. Journal of the American Academy of Child and Adolescent Psychiatry,
39, 1284–1292.
Luna, B.. & Sweeney, J. A. (2004). The emergence of collaborative brain function.
Annals of the New York Academy of Sciences, 1021, 296–309.
Maine, M. (2000). Body wars: Making peace with women’s bodies. Carlsbad, CA: Gurze
Books.
Marrazzi, M. A., Bacon, J. P., Kinzie, J., et al. (1995). Naltexone use in the treatment of
anorexia nervosa and bulimia nervosa. International Clinical
Psychopharmacology, 10, 163.
Marrazzi, M. A., & Luby, E. D. (1986). An auto-addiction opioid model of chronic
anorexia nervosa. International Journal of Eating Disorders, 5, 191–208.
Marshall, R. D., Blanco, C., Printz, D., Liebowitz, M. R., Klein, D. F., & Coplan, J.
(2002). A pilot study of noradrenergic and HPA axis functioning in PTSD vs.
panic disorder. Psychiatry Research, 110, 219–230.
Mazzeo, S. E., & Espelage, D. L. (2002). Association between childhood physical and
emotional abuse and disordered eating in female college students. Journal of
Counseling Psychology, 49, 86–100.

115

McIntosh, V. W., Jordan, J., Carter, F. A., Luty, S. E., et al. (2005). Three
psychotherapies for anorexia nervosa: A randomized controlled trial. American
Journal of Psychiatry, 162, 741–747.
Meyer, C., Serpell, L., Waller, G., Murphy, F., Treasure. J., & Leung, N. (2005).
Cognitive avoidance in the strategic processing of ego threats among eatingdisordered patients. International Journal of Eating Disorders, 38, 30–36.
Mintz, L. B., & Betz, N. E. (1988). Prevalence and correlates of eating disordered
behaviors among undergraduate women. Journal of Counseling Psychology, 463–
471.
Mintz, L. B., O’Halloran, M. S., Mulholland, A. M., & Schneider, P. A. (1997).
Questionnaire for eating disorder diagnoses: Reliability and validity of
operationalizing DSM-IV criteria into a self-report format. Journal of Counseling
Psychology, 44, 63–79.
Mitchell, J. E., Christenson, G., Jennings, J., Huber, M., Thomas, B., Pomeroy, C., et al.
(1989). A placebo-controlled, double-blind crossover study of naltrexone
hydrochloride in outpatients with normal weight bulimia. Journal of Clinical
Psychopharmacology, 9, 94–97.
Mitchell, J. E., de Zwaan, M., & Roerig, J. L. (2003). Drug therapy for patients with
eating disorders. Current Drug Targets—CNS & Neurological Disorders, 2, 17–
29.
Mohr, D. C. (1995). Negative outcome in psychotherapy: A critical review. Clinical
Psychology: Science and Practice, 2, 1–27.
Morris, J. S., & Dolan, R. J. (2001). Involvement of human amygdale and orbitofrontal
cortex in hunger-enhanced memory for food stimuli. Journal of Neuroscience, 21,
5304–5310.
Müller, R., & Büttner, P. (1994). A critical discussion of intraclass correlation
coefficients. Statistics in Medicine, 13, 2465–2476.
National Institute of Mental Health. (2001). Eating disorders: Facts about eating
disorders and the search for solutions. Bethesda, MD: Department of Health and
Human Services.
Nelson, E. E., Liebenluft, E., McClure, E. B., & Pine, D. S. (2005). The social reorientation of adolescence: A neuroscience perspective on the process and its
relation to psychopathology. Psychological Medicine, 35, 163–174.
Nielsen, S. L., & Goates, M. K. (2002). Enhancing psychotherapy outcomes via
providing feedback on client progress: A replication. Clinical Psychology and
Psychotherapy, 9, 91–103.

116

Nestler, E. J. (2004). Historical review: Molecular and cellular mechanisms of opiate and
cocaine addiction. Trends Pharmacology Science, 25, 210–218.
Nichter, M., & Nichter, M. (1991). Hype and weight. Medical Anthropology, 13, 249–
284.
Nishijo, H., Ono, T., & Nishino, H. (1988). Single neuron responses in amygdala of alert
monkey during complex sensory stimulation with affective significance. Journal
of Neuroscience, 8, 3570–3583.
Noordenbox, G. (2002). Characteristics and treatment of patients with chronic eating
disorders. International Journal of Eating Disorders, 10, 15–29.
Nozoe, S., Naruo, T., Yonekura, R., Nakabeppu, Y., Soejima, Y., & Nagai, N. (1995).
Comparison of regional cerebral blood flow in patients with eating disorders.
Brain Research Bulletin, 36, 251–255.
Olds, J. (1962). Hypothalamic substrates of reward. Physiology Review, 42, 554–604.
Ousley, L. B. (1986). Differences among bulimic subgroups, binge-eaters, and normal
eaters in a female college population. Unpublished doctoral dissertation,
University of Florida.
Overduin, J., & Jansen, A. (1995). The conditioning model of binge eating. In B. Tuschen
& I. Floren (Eds.), Current research in eating disorders (pp. 16–27). Munster:
Verlag fur Psychotherpie.
Overduin, J., & Jansen, A. (1996). Food cue reactivity in fasting and non-fasting subjects.
European Eating Disorders Review, 4, 249–259.
Paris, J., Zweig-Frank, H., Ng Ying Kin, N. M. K., Schwartz, G., Steiger. H., & Nair, N.
P. V. (2004). Neorobiological correlates of diagnosis underlying traits in patients
with borderline personality disorder compared with normal controls. Psychiatry
Research, 121, 239–252.
Percevic, R. (2003, June). A strategy for improving outcome quality through continuous
outcome monitoring. SPR 34th Annual Meeting, Weimar, Germany.
Percevic, R., Lambert, M. J., & Kordy, H. (2004). Computer supported monitoring of
patient treatment progress. Journal of Clinical Psychology, 60, 285–299.
Phelps, L., Johnston, L. S., & Augustyniak, K. (1999). Prevention of eating disorder:
identification of predictor variables. Eating Disorders: The Journal of Treatment
and Prevention 7, 99–108.
Pike, K. M. (1995). Bulimic symptomatology in high school girls: Towards a model of
cumulative risk. Psychology of Women Quarterly 19, 373–396.

117

Pipher, M. (1994). Reviving Ophelia: Saving the selves of adolescent girls. New York:
Putnam.
Polivy, J., & Herman, C. P. (1999). The effects of resolving to diet on restrained and
unrestrained eaters. The “false hope syndrome.” International Journal of Eating
Disorders, 26, 434–447.
Powers, P. S., Santana, C. A., & Bannon, Y. S. (2002). Olanzapine in the treatment of
anorexia nervosa: An open label trial. International Journal of Eating Disorders,
32, 146.
Raudenbush, S. W., & Byrk, A. S. (2002). Hierarchical linear models: Applications and
data analysis methods (2nd ed.). Thousand Oaks, CA: Sage Publications.
Raudenbush, S. W., Bryk, A. S., Cheong, Y. F., & Congdon, R. T., Jr. (2000). HLM5.
Chicago, IL: Scientific Software.
Rodin, J., Silberstein, L. R., & Striegel-Moore, R. H. (1985). Women and weight: A
normative discontent. In T. B. Sonderegger (Ed.), Nebraska symposium on
motivation, Vol. 32: Psychology and gender (pp. 267–307). Lincoln: University of
Nebraska.
Rolls, E. T. (2000). The orbitofrontal cortex and reward. Cerebral Cortex, 10, 284–294.
Rolls, E. T., Rolls, B. J., & Rowe, E. A. (1982). Sensory-specific and motivation-specific
satiety for the sight and taste of food and water in man. Physiology and Behavior,
30, 185–192.
Rolls, E. T., Sienkiewicz, Z. J., & Yaxley, S. (1989) Hunger modulates the responses to
gustatory stimuli of single neurons in the caudolateral orbitofrontal cortex of the
macaque monkey. European Journal of Neuroscience, 1, 53–60.
Rolls, E. T., Yaxley, S., & Sienkiewicz, Z. J. (1990). Gustatory responses of single
neurons in the orbitofrontal cortex of the macaque monkey. Journal of
Neurophysiology, 64, 1055–1066
Romano, S. J., Halmi, K. A., Sarkar, N. P., Koke, S. C., & Lee, J. S. (2002). A placebocontrolled study of fluoxetine in continued treatment of bulimia nervosa after
successful acute fluoxetine treatment. American Journal of Psychiatry, 151, 96–
102.
Rosenberg, H., & Davis, L. A. (1994). Acceptance of moderate drinking by alcohol
treatment services in the United States. Journal of Studies on Alcohol, 55, 167–
172.
Rosenberg, H., Devine, E. G., & Rothrock, N. (1995). Acceptance of moderate drinking
by alcoholism treatment services in Canada. Journal of Studies on Alcohol, 57,
559–562.
118

Rubia, K., Smith, A., & Taylor, E. (2005). Performance of children with attention deficit
hyperactivity disorder (ADHD) on a biological marker test battery for
impulsiveness. International Journal of Neuropsychology, 29, 918–943.
Sanghera, M. K., Rolls, E. T., & Roper-Hall, A. (1979). Visual responses of neurons in
the dorsolateral amygdala of the alert monkey. Experimental Neurology, 63, 610–
626.
Scarano, G. M., & Kalodner-Martin, C. R. (1994). A description of the continuum of
eating disorders: Implications for intervention and research. Journal of
Counseling and Development, 72(4), 356–361.
Schmidt, U., Jiwany, A., & Treasure, J. (1993). A controlled study of alexithymia in
eating disorders. Comprehensive Psychiatry, 34, 54–58.
Schmidt, U., & Treasure, J. (2005). Anorexia nervosa: Valued and visible. A cognitiveinterpersonal maintenance model and its implications for research and practice.
British Journal of Clinical Psychology, 46, 413-428.
Shapiro, J. R., Berkman, N. D., Brownley, K. A., Sedway, J. A., Lohr, K. N., et al.
(2004). Bulimia nervosa treatment: A systematic review of randomized controlled
trials. International Journal of Eating Disorders, 40, 323–334.
Shapiro, D. A., & Shapiro, D. (1982). Meta-analysis of comparative therapy outcome
research: A critical appraisal. Behavioral Psychotherapy, 10, 4–25.
Simansky, K. (2005). NIH symposium series: Ingestive mechanisms in obesity, substance
abuse and mental disorders. Physiology and Behavior, 86, 1–4.
Skinner, H. A. (1986). Construct validation approach to psychiatric classification. In T.
Millon & G. L. Klerman (Eds.), Contemporary directions in psychopathology:
Toward the DSM–IV (pp. 307–330). New York: Guilford Press.
Smith, M. L., Glass, G. V., & Miller, T. I. (1980). The benefits of psychotherapy.
Baltimore: John Hopkins University Press.
Smolak, L., & Levine, M. P. (1996). Developmental transitions at middle school and
college. In L. Smolak, M. P. Levine, & R. H. Striegel-Moore (Eds.), The
developmental psychopathology of eating disorders: Implications for research,
prevention, and treatment (pp. 207–233). Hillsdale, NJ: Erlbaum.
Solso, R. L., MacLin, M. K., & MacLin, O. H. (2005). Cognitive psychology (7th ed.).
Boston: Pearson, Allyn & Bacon.
Southgate, L., Tchanturia, K., & Treasure, J. (2005). Building a model of the aetiology of
eating disorders by translating experimental neuroscience into clinical practice.
Journal of Mental Health, 14, 554–565.

119

Spitzer, F. (2001). Principles of random walk. Heidelberg, Germany: Springer.
Stein, K. F., & Corte, C. (2003). Reconceptualizing causative factors and intervention
strategies in the eating disorders: A shift from body image to self-concept
impairments. Archives of Psychiatric Nursing, 17, 57–66.
Stevelmans, E., et al. (2004). Emotional functioning in anorexia nervosa patients:
Adolescents compared to adults. Depression & Anxiety, 19, 35–42.
Stice, E., Marti, C. N., Spoor, S., Presnell, K., & Shaw, H. (2008). Dissonance and
healthy weight eating disorder prevention programs: Long-term effects from a
randomized efficacy trial. Journal of Consulting and Clinical Psychology, 76,
329–340.
Stice, E., Nemeroff, C., & Shaw, H. (1996). Test of the dual pathway model of bulimia
nervosa: Evidence for dietary restraint and affect regulation mechanisms. Journal
of Social and Clinical Psychology, 15, 340–363.
Tabachnick, B. G., & Fidell, L. S. (1996). Using multivariate statistics (4th ed.). Boston:
Allyn & Bacon.
Thompson, J. K., Heinberg, L. J., Altabe, M., & Tantleff-Dunn, S. (1999). Exacting
beauty: Theory, assessment, and treatment of body image disturbance.
Washington, DC: American Psychological Association.
Tobin, D., Banker, J., Weisberg, L., & Bowers, W. (2007, December). I know what you
did last summer (and it was not CBT): A factor analytic model of international
psychotherapeutic practice in the eating disorders. International Journal of Eating
Disorders, 40, 754–757.
Trull, T. J. (2001). Clinical psychology: Concepts, methods, and professions (6th ed.).
Australia: Wadsworth
Tylka, L. T., & Subich, L. M. (1999). Exploring the construct validity of the eating
disorder continuum. Journal of Counseling Psychology, 46, 268–276.
Walsh, B. T., Fairburn, G. C., Mickley, D., Sysko, R., & Parides, M. K. (2004).
Treatment of bulimia nervosa in a primary care setting. American Journal of
Psychiatry, 161, 556–561.
Wang, G. J., Volkow, N. D., Thanos, P. K., & Fowler, J. S. W. (2004). Similarity
between obesity and drug addiction as assessed by neurofunctional imaging: A
concept review. Journal of Addictive Diseases, 23, 39–53.
Weisner, C. (1995). Controlled drinking issues in the 1990s: The public health model and
specialty treatment. Addiction, 90, 1164–1166.

120

Wells, K. B. (1999). Treatment research at the crossroads: The scientific interface of
clinical trials and effectiveness research. American Journal of Psychiatry, 156, 5–
10.
Wells, M. G., Burlingame, G. M., & Lambert, M. J. (1999). Youth outcome
questionnaire. In M. E. Maruish (Ed.), The use of psychological testing for
treatment planning and outcome assessment (2nd ed.). Mahwah, NJ: Erlbaum.
Williams, R. L., & Thompson, J. K. (2000). A laboratory study of media exposure and
body image: Disentangling the role of model and product. Paper presented at the
9th Academy of Eating Disorders convention, New York.
Wise, R. A. (1997). Drug self-administration viewed as ingestive behavior. Appetite, 28,
1–5.
Wise, R. A. (2004). Dopamine, learning, and motivation, Nature Reviews Neuroscience,
5, 483–494.
Wonderlich, S. A., Joiner, T. E., Keel, P. K., Williamson, D. A., Crosby, R. D. (2007).
Eating disorder diagnoses: Empirical approaches to classification. American
Psychologist, 62, 167–180.
Yager, J., Devlin, M. J., Halmi, K. A., Herzog, D. B., Mitchell, J. B., Powers, P. S., &
Zerbe, K. J. (2005). Guideline watch: Practice guideline for the treatment of
patients with eating disorders (2nd ed.) American Psychiatric Association.
Yan, G., & Sedransk, J. (2010). A note on Bayesian residuals as a hierarchical model
diagnostic technique. Statistical Papers, 51, 1–10.
Zonnevylle-Bendek, M. J. S., van Goozen, S. H. M., Cohen-Kettenis, P. T., van Elburg,
A., & van Engeland, H. (2002). Do adolescent anorexia nervosa patients have
deficits in emotion functioning? European Child & Adolescent Psychiatry, 11,
38–42.

121

